Section 48

EurekaMag PDF full texts Chapter 47,529


Volz, T.J.; Clausen, T.P. 2001: Tannins in Puccinellia arctica: possible deterrents to herbivory by Canada geese. Journal of Chemical Ecology 27(4): 725-732
Khanbabaee, K.; van Ree, T. 2001: Tannins: classification and definition. Natural Product Reports 18(6): 641-649
Carmona, A. 1996: Tannins: thermostable pigments which complex dietary proteins and inhibit digestive enzymes. Archivos Latinoamericanos de Nutricion 44(4 Suppl 1: 31s-35s
Yoon, Y.; Kim, Y.O.; Jeon, W.K.; Park, H.J.; Sung, H.J. 1999: Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. Journal of Ethnopharmacology 68(1-3): 121-127
Chen, H.; Yuan, J.P.; Chen, F.; Zhang, Y.L.; Song, J.Y. 1997: Tanshinone production in Ti-transformed Salvia miltiorrhiza cell suspension cultures. Journal of Biotechnology 58(3): 147-156
Gilja, I. 2000: Tansvaginal needle suspension operation: the way we do it. Clinical and urodynamic study: long-term results. European Urology 37(3): 325-330
Qasmi, S.H.; Tusi, N.a. 1985: Tansūkh Nāmeh-ī Ilkhānī--a unique Persian work on gemology. Studies in History of Medicine and Science 9(1-2): 67-74
Guzei, I.A..; Yap, G.P.. A..; Winter, C.H.. 1997: Tantalum Complexes Bearing eta(1)-, eta(2)-, and "Slipped" eta(2)-Pyrazolato Ligands. Inorganic Chemistry 36(9): 1738-1739
Eldridge, J.D.; Avramidis, K.; Lee, M.; Learmonth, I.D. 1998: Tantalum ball position after total hip arthroplasty. Journal of Bone and Joint Surgery. British Volume 80(3): 414-416
Fontaine, A.B.; Dake, M.D.; Tschang, T.P.; Guertin, S.; Stabbe, M.T.; Dos Passos, S. 1993: Tantalum balloon-expandable stent: in vivo swine studies. Journal of Vascular and Interventional Radiology: Jvir 4(6): 749-752
Matsuda, T.; Yamaguma, M. 2000: Tantalum dust deflagration in a bag filter dust-collecting device. Journal of Hazardous Materials 77(1-3): 33-42
Rubenstein, L.K.; Strauss, R.A.; Lindauer, S.J.; Davidovitch, M.; Isaacson, R.J. 1993: Tantalum implants as markers for evaluating postoperative orthognathic surgical changes. International Journal of Adult Orthodontics and Orthognathic Surgery 8(3): 203-209
Bakhmutov, V.I..; Vorontsov, E.V..; Bakhmutova, E.V..; Boni, G.; Moise, C. 1999: Tantalum-Gold and Tantalum-Copper Trihydride Complexes [Cp'(2)TaH(3)MPPh(3)][PF(6)] (Cp' = C(5)H(4)C(CH(3))(3)). Structure Determination from (1)H T(1) Relaxation Studies. Inorganic Chemistry 38(6): 1121-1125
Lundqvist, A.; Pihl, J.; Orwar, O. 2000: Tantalum-filament pulling device for fabrication of submicrometer fused-silica tips. Analytical Chemistry 72(22): 5740-5743
Wittkowski, W. 1998: Tanycytes and pituicytes: morphological and functional aspects of neuroglial interaction. Microscopy Research and Technique 41(1): 29-42
Anonymous 1986: Tanzania. Department of State publication. Background notes series 1986: 1-8
Shabalin, A.V.; Vergeĭchik, T.K. 1993: Method of isolating carbamazepine from cadaveric material and its determination by fluorescent polarization immunoassay. Sudebno-Meditsinskaia Ekspertiza 36(4): 29-30
Orel, N.F. 1998: Taxotere in various solid tumors. Voprosy Onkologii 44(5): 639-644
Anonymous 1993: Tanzania DHS survey reveals gaps in AIDS knowledge. Newsletter 6(1): 8-9
Anonymous 1998: Tanzania benefits from inter-organizational cooperation. Joicfp News 1998(290): 4
Siringi, S. 2002: Tanzania loses Global Fund money because of internal wrangling. Lancet 360(9348): 1848
Carlough, M. 1997: More than hospitals are needed in Nepal. Safe Motherhood 24: 9-10
Mosha, H.J.; Mgalula, N.E. 1996: Tanzania oral health workers' views on the relevance of their training to their duties. East African Medical Journal 73(7): 443-447
Taverne, J. 2001: Tanzania phases out chloroquine for the treatment of malaria. Trends in Parasitology 17(8): 360
Siringi, S. 2002: Tanzania rail crash highlights lack of medical resources for disasters. Lancet 360(9326): 65
Anonymous 1994: Tanzania survey points to high risk of maternal death. Safe motherhood 1994(13): 1-2
Yudkin, J.S. 1999: Tanzania: still optimistic after all these years?. Lancet 353(9163): 1519-1521
Fox, R. 2000: Tanzanian AIDS project works towards "good things for young people". Lancet 355(9216): 1703
Lugina, H.I.; Lindmark, G.; Johansson, E.; Christensson, K. 2001: Tanzanian midwives' views on becoming a good resource and support person for postpartum women. Midwifery 17(4): 267-278
Anonymous 1996: Tanzanian project expands. Joicfp News 1996(267): 5
Finger, W.R. 1994: Tanzanian projects seek "safe motherhood". Network 14(3): 22-23
Walker, C.A. 1998: Taoism: the way. Journal of the Medical Association of Georgia 87(4): 300-302
Xiao, S.; Young, D.; Zhang, H. 1998: Taoistic cognitive psychotherapy for neurotic patients: a preliminary clinical trial. Psychiatry and Clinical Neurosciences 52 Suppl: S238-S241
Cohen, K.S. 1999: Taoists eat their words, too. Alternative Therapies in Health and Medicine 5(1): 18
Shulman, K.I.; Tailor, S.A.; Walker, S.E.; Gardner, D.M. 1997: Tap (draft) beer and monoamine oxidase inhibitor dietary restrictions. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 42(3): 310-312
Bove, L.A. 2002: Tap Internet employment resources. Nursing Management 33(6): 51-52
Moore, J. 2000: Tap a \$1.1 trillion resource. Contemporary Longterm Care 23(10): 49
Sinclaire, J.K. 1980: Tap all sources in search for major gifts. Fund Raising Management 11(6): 14-17
Ferguson, T. 1982: Tap employees' resources, advises self-care expert. Employee Health and Fitness 4(12): 137-140
Knapp, M.L. 1998: Community health improvement: it's time for action. Quality Letter for Healthcare Leaders 10(1): 13-16
Tourangeau, A.; MacLeod, F.; Breakwell, M. 1993: Tap in on ear thermometry. Canadian Nurse 89(8): 24-28
Tweedy, D.A. 1985: Tap in-house, vendor help for RMIS. Business Insurance 19(42): 50
Metcalf, R. 2002: Tap into a new workforce. Nursing Management 33(6): 24-25
Anonymous 1997: Tap into patient data to bolster your DM programs. Healthcare Demand and Disease Management 3(7): 97-101
Tomioka, T.; Ikematsu, Y.; Tajima, Y.; Sasaki, M.; Tsunoda, T.; Kanematsu, T. 1994: Tap needle for laparoscopic surgery: a safe and easy technique for holding tissues. Surgical Laparoscopy and Endoscopy 4(5): 361-363
Anonymous 1997: Tap power of the mind to improve outcomes for high-risk diabetics. Healthcare Demand and Disease Management 3(7): 108-110
Gomez, E. 2000: Tap the Internet to strengthen evidence-based oncology nursing practice. Ons News 15(6): 7
Anonymous 1996: Tap water and HIV. Pediatric Aids and HIV Infection 7(6): 478
Riyat, M.S.; Quinton, D.N. 1997: Tap water as a wound cleansing agent in accident and emergency. Journal of Accident and Emergency Medicine 14(3): 165-166
Bansal, B.C.; Wiebe, R.A.; Perkins, S.D.; Abramo, T.J. 2002: Tap water for irrigation of lacerations. American Journal of Emergency Medicine 20(5): 469-472
Churina, S.K.; Ianushkene, T.S.; Eschanova, G.T.; Makarov, V.L. 1999: Tap water magnesium deficiency modulate arterial blood pressure, Ca and Mg tissue distribution, and compartmentation of membrane-bound calcium in thrombocytes of normotensive WKY rats. Biulleten' Eksperimental'noi Biologii i Meditsiny 127(2): 183-186
Feldman, K.W.; Schaller, R.T.; Feldman, J.A.; McMillon, M. 1998: Tap water scald burns in children. 1997. Injury Prevention: Journal of the International Society for Child and Adolescent Injury Prevention 4(3): 238-242
Katcher, M.L. 1998: Tap water scald prevention: it's time for a worldwide effort. Injury Prevention: Journal of the International Society for Child and Adolescent Injury Prevention 4(3): 167-168
Waller, A.E.; Langley, J.D.; Clarke, J. 1994: Tap water scalds in New Zealand. American Journal of Public Health 84(9): 1524
Crawford, S.Y. 1993: Tap water should not be used. American Journal of Hospital Pharmacy 50(8): 1579
Harris 1998: Tap water tempest. Current Biology: Cb 8(9): R294
Laurent, C. 1993: Tap-dancing to health. Nursing Times 89(18): 18
Raghuraman, G.; Lapinski, P.E.; Raghavan, M. 2002: Tapasin interacts with the membrane-spanning domains of both TAP subunits and enhances the structural stability of TAP1 x TAP2 Complexes. Journal of Biological Chemistry 277(44): 41786-41794
Momburg, F.; Tan, P. 2002: Tapasin-the keystone of the loading complex optimizing peptide binding by MHC class i molecules in the endoplasmic reticulum. Molecular Immunology 39(3-4): 217-233
Fichtelius, K.E. 1999: Tape as a help in sleep apnea. Lakartidningen 96(49): 5524-5525
Farnsworth, C.H.; Bastable, A.; Kevorkian, J. 1996: Tape recalls a Canadian's gratitude to Kevorkian. New York Times on the Web 1996: A17
Nyquist, K.; Finkel, Y. 1996: Tape recorded consultations are a good support. Lakartidningen 93(26-27): 2493
Lumley, P.J.; Harrington, E.; Walmsley, A.D.; Marquis, P.M. 1996: Taper and stiffness of sonic endodontic files. Endodontics and Dental Traumatology 12(2): 77-81
Becker, P.; Gribben, R.J.; Lim, C.M. 2000: Tapered conduits can buffer hydraulic conductance from path-length effects. Tree Physiology 20(14): 965-967
Eichmiller, F.C.; Parry, E.E. 1994: Tapered cross-pin attachments for fixed bridges. Operative Dentistry 19(1): 7-10
Mallory, T.H.; Head, W.C.; Lombardi, A.V. 1997: Tapered design for the cementless total hip arthroplasty femoral component. Clinical Orthopaedics and Related Research 344: 172-178
Pilevar, S.; Davis, C.C.; Portugal, F. 1998: Tapered optical fiber sensor using near-infrared fluorophores to assay hybridization. Analytical Chemistry 70(10): 2031-2037
Dunlop, D.J.; Masri, B.A.; Greidanus, N.V.; Garbuz, D.S.; Duncan, C.P. 2002: Tapered stems in cemented primary total hip replacement. Instructional Course Lectures 51: 81-91
Bourne, R.B.; Rorabeck, C.H.; Patterson, J.J.; Guerin, J. 2001: Tapered titanium cementless total hip replacements: a 10- to 13-year followup study. Clinical Orthopaedics and Related Research 393: 112-120
Schipper, I.; Senn, P.; Lechner, A. 1995: Tapered transition zone and surface smoothing ameliorate the results of excimer-laser photorefractive keratectomy for myopia. German Journal of Ophthalmology 4(6): 368-373
Zipf, A. 1993: Tapered treatment with corticosteroids. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 44(3): 180
Silverman, W.B. 1997: Tapered-tip, triple-lumen papillotome/cannula facilitates cannulation yet accepts standard guidewires. Gastrointestinal Endoscopy 46(5): 471-472
Belli, L.S.; Alberti, A.B.; Vangeli, M.; Airoldi, A.; Pinzello, G. 2003: Tapering off steroids three months after liver transplantation is not detrimental for hepatitis C virus disease recurrence. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 9(2): 201-202
Sanders, C.E.; Curtis, J.J.; Julian, B.A.; Gaston, R.S.; Jones, P.A.; Laskow, D.A.; Deierhoi, M.H.; Barber, W.H.; Diethelm, A.G. 1993: Tapering or discontinuing cyclosporine for financial reasons--a single-center experience. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 21(1): 9-15
Severns, A. 1996: Tapestry of tears. Nln Update: Connecting Members of the National League for Nursing 2(2): 6-7 13
Angen, M.J.; MacRae, J.Helen.; Simpson, J.Steven.A.; Hundleby, M. 2002: Tapestry: a retreat program of support for persons living with cancer. Cancer Practice 10(6): 297-304
Zhao, Z.F.; Guo, H.; Huang, X.X. 1997: Tapeworm infection resulting from pork eaten at a wedding banquet. Southeast Asian Journal of Tropical Medicine and Public Health 28(Suppl 1): 20-21
Schantz, P.M. 1996: Tapeworms (cestodiasis). Gastroenterology Clinics of North America 25(3): 637-653
Dietrichs, E.; Tyssvang, T.; Aanonsen, N.O.; Bakke, S.J.; Skullerud, K. 1994: Tapeworms in the brain--a current problem in Norway?. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(26): 3089-3092
Stradowski, M. 1997: Tapeworms morphological changeability in the chain of Hymenolepis diminuta WMS "strain" generations. Wiadomosci Parazytologiczne 43(1): 61-68
Emmanuel, E.R. 1993: Taping ETT connectors. Anaesthesia and Intensive Care 21(3): 380
Meyer, K. 1983: Are admitters liable in suits against impaired physicians?. Hospital Admitting Monthly 2(9): 116-117
Anonymous 1998: Taping meetings in the hospital. Hernandez v. McDonald's Corporation. Hospital Law Newsletter 15(6): 1-3
Agnew, P.S. 1993: Taping of foot and ankle for Korean karate. Journal of the American Podiatric Medical Association 83(9): 534-536
Leanderson, J.; Ekstam, S.; Salomonsson, C. 1996: Taping of the ankle--the effect on postural sway during perturbation, before and after a training session. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 4(1): 53-56
Cox, S.S. 1994: Taping report: tips to record by. Nursing 24(3): 64
Baquie, P. 2002: Taping. General principles. Australian Family Physician 31(2): 155-157
Durette-Desset, M.C.; Chabaud, A.G.; Sutton, C.A. 1997: Tapironema coronatum n. gen., n. sp. (Trichostrongyloidea-Cooperiidae-Obeliscoidinae), a parasite of Holochilus brasiliensis and Tapirus terrestris. Parasite 4(3): 227-232
Taylor, M. 2001: Tapped for \$800 million. Drugmakers' joint venture will pay what could be biggest fraud settlement. Modern Healthcare 31(17): 8-9
Anonymous 2002: Tapped out? Americans' love affair with bottled water continues to grow, but.... Dentistry Today 21(9): 32 37
Taylor, C. 1999: Tapping Disney inspiration: transforming healthcare. Hospital Quarterly 3(2): 25-27
Lange, R. 1983: Tapping a valuable resource--the employee. Radiology Management 5(2): 27-28
Kahler, S.C. 2001: Tapping a "tremendous resource"--allied group expertise. Journal of the American Veterinary Medical Association 218(5): 654-655
Hammer, M.L.; Johns, E.A. 1993: Tapping an Amazônian plethora: four medicinal plants of Marajó Island, Pará (Brazil). Journal of Ethnopharmacology 40(1): 53-75
Divinagracia, E.R. 1998: Tapping and involving the youth. NGOs can do a lot in advancing adolescent reproductive health. Integration 56: 23-25
Kinney, E.D. 2000: Tapping and resolving consumer concerns about health care. American journal of law & medicine 26(4): 335-399
Sarter, M.; Berntson, G.G. 1999: Tapping artificially into natural talents. Trends in Neurosciences 22(7): 300-302
Rampp, L.C. 1978: Tapping federal information systems. Emergency Medical Services 7(3): 68-73
Martin, D.K. 1984: Tapping for information systems. Computers in Healthcare 5(12): 32-36
Moore, J.D. 1999: Tapping hidden resources. Healthcare is preparing minorities to move into the executive suite. Modern Healthcare 29(50): 30
Heid, M.C. 1983: Tapping human resources in the '80s. Cross-Reference on Human Resources Management 13(2): 1-3
Alter, K.L. 1994: Tapping in to new technology. Close links to patients at home. Caring: National Association for Home Care Magazine 13(2): 12-13; 48-49
Dawes, H. 2001: Tapping into genome secrets. Current Biology: Cb 11(11): R416-R417
Gross, K. 1997: Tapping into the Internet--one LNC's experience. National Medical-Legal Journal 8(2): 5
Davis, R.E. 1996: Tapping into the culture of homelessness. Journal of Professional Nursing: Official Journal of the American Association of Colleges of Nursing 12(3): 176-183
Wallon, G. 2002: Tapping into the pool of women. Facing a serious shortage of skilled workers, Europe's high-tech economies are discovering the value of working women. Embo Reports 3(4): 302-304
Baker, H.K. 1981: Tapping into the power of informal groups. Supervisory Management 26(2): 18-25
Milazzo, V.L. 1998: Tapping into your personal power. National Medical-Legal Journal 9(3): 2
Hardy, G. 1992: Tapping new revenues. how to bill Medicare Part-B directly for prosthetics and orthotics products. Contemporary Longterm Care 15(1): 30; 32
De Gennes, P.-G. 2000: Tapping of Granular Packs: a Model Based on Local Two-Level Systems. Journal of Colloid and Interface Science 226(1): 1-4
Guzman, P.M.; Sliepcevich, E.M.; Lacey, E.P.; Vitello, E.M.; Matten, M.R.; Woehlke, P.L.; Wright, W.R. 1988: Tapping patient satisfaction: a strategy for quality assessment. Patient Education and Counseling 12(3): 225-233
Monroe, S.M. 1998: Tapping private equity to finance your dream. Contemporary Longterm Care 21(12): 65-66
Weerakoon, B. 1986: Tapping private industry. Draper Fund Report 1986(15): 9-14
Shively, D. 1984: Tapping satellite communications' potential. Suppliers must key on hospital administrator's concerns in an era of rapidly changing business conditions. Biomedical Communications 12(5): 22-23
Masur, S.; Kane, C.M. 2001: Tapping science's women for the podium. Science 294(5551): 2480
Fortin, C.; Duchet, M.L.; Rousseau, R. 1996: Tapping sensitivity to processing in short-term memory. Canadian Journal of Experimental Psychology 50(4): 402-407
Khan, M.K. 1982: Tapping society's resources. Hospital Trustee 6(3): 8-9
Dean, D.S.; Lefèvre, A. 2001: Tapping spin glasses and ferromagnets on random graphs. Physical Review Letters 86(25): 5639-5642
Chewning, B.A. 1983: Tapping the client's own potential: a strategy for the resource-short patient educator. Promoting Health 4(2): 4-6
Morinis, E.A. 1980: Tapping the flow of information in a rural region: the example of the smallpox eradication program in Bihar, India. Human Organization 39(2): 180-184
Anonymous 1987: Tapping the fountain of youth. Profiles in hospital marketing 1987(27): 64-67
Campbell, L.; Parker, M. 1989: Tapping the internal marketing advantage. Caring: National Association for Home Care Magazine 8(12): 35-37
Moore, J. 1992: Tapping the largest single capital source. Senior's home is sponsor's biggest competitor. Contemporary Longterm Care 15(12): 26 83
Meager, N.; Buchan, J. 1990: Tapping the market. Health Service Journal 100(5211): 1108-1110
Levison, J. 1989: Tapping the older adult market. Volunteer Leader 30(2): 7; 16
Page, E.P. 2002: Tapping the potential in resistance. Seminars for Nurse Managers 10(3): 180-188
La Puma, J.; Eiler, G. 1998: Tapping the potential of alternative medicine. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 52(4): 41-44
Enos, G. 2002: Tapping the potential of isomer science. Behavioral Healthcare Tomorrow 11(1): Sr30-Sr31
Middleton, G. 2002: Tapping the potential of paging. Emergency Medical Services 31(8): 81
Gewertz, B.L.; Goode, L.D.; Behrens, B.L.; Fortuner, W.J.; Wallace, A.G.; Williams, W.T.; Wilson, D.E. 1997: Tapping the power of information: an orientation for academic medical centers. Academic Medicine: Journal of the Association of American Medical Colleges 72(8): 677-681
Brody, H. 2000: Tapping the power of the placebo. Sugar pills are potent medicine when taken in the right spirit. can we put them to practical use?. Newsweek 136(7): 66
Levin, R. 1987: Tapping the retiree voluntary sector. Business and Health 4(12): 20-21
Leader, S.; Mallick, R. 1998: Tapping the savings from vitamin-based prevention. Managed Care Interface 11(10): 95-99
Hickey, J.C. 1978: Tapping the talents of the older volunteer. Volunteer Leader 19(4): 17-22
Clarke, M.; Findlay, A.; Canac, J.F.; Vergez, A. 1996: Tapping the television cable. Journal of Telemedicine and Telecare 2 Suppl. 1: 89-91
Pearlman, D.N.; Camberg, L.; Wallace, L.Jo.; Symons, P.; Finison, L. 2002: Tapping youth as agents for change: evaluation of a peer leadership HIV/AIDS intervention. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 31(1): 31-39
Lu, N.H.; Lin, W.C.; Tsai, D.P. 2001: Tapping-mode tuning-fork near-field scanning optical microscopy of low power semiconductor lasers. Journal of Microscopy 202(Part 1): 172-175
Shoji, M.; Kanai, M.; Matsubara, E.; Ikeda, M.; Harigaya, Y.; Okamoto, K.; Hirai, S. 2000: Taps to Alzheimer's patients: a continuous Japanese study of cerebrospinal fluid biomarkers. Annals of Neurology 48(3): 402
Welch, S.G.; Williams, R.A. 1995: Taq52 I, a novel and thermostable type Ii restriction endonuclease from the genus Thermus, recognising the pentanucleotide sequence GC(A or T)GC and cleaving DNA between the first and second bases of the recognition sequence: G decreased or reduced C(A or T)GC. Nucleic Acids Research 23(22): 4573-4575
Gelernter, J.; Kruger, S.; Kidd, K.K.; Amara, S. 1993: Taqi RFLP at norepinephrine transporter protein (NET) locus. Human Molecular Genetics 2(6): 820
Burn, A.L.; Clarke, R.A.; Beh, K.J. 1993: Taqi RFLP at the bovine IgE gene locus. Animal Genetics 24(5): 397
Ryan, A.M.; Womack, J.E.; Lin, J.H.; Sun, T.T. 1994: TaqI RFLPs at the bovine uroplakin II locus (UPK2). Animal Genetics 25(1): 58
Bumstead, N.; Young, J.R.; Tregaskes, C. 1993: Taqi and HaeIIi RFLP at the locus encoding the chicken homologue of CD28. Animal Genetics 24(4): 328
Girard-Santosuosso, O.; Lantier, I.; Millet, N.; Mouline, C.; Guillot, J.F.; Protais, J.; Colin, P.; Beaumont, C.; Lantier, F. 1996: Taqi and HindIIi RFLPs at the chicken PAX3 locus. Animal Genetics 27(5): 374-375
Richards, F.M.; Latif, F.; Lerman, M.I.; Zbar, B.; Maher, E.R. 1993: Taqi and Psti RFLPs in the von Hippel-Lindau disease gene (VHL). Human Molecular Genetics 2(10): 1750
Redeker, E.; Van Moorsel, C.J.; Feinberg, A.; Mannens, M. 1993: Taqi and Rsai polymorphisms in the H19 gene (D11S813E). Human Molecular Genetics 2(6): 823
Saksova, L.; Gecz, J.; Kadasi, L.; Ferak, V. 1993: Taqi digestion of PCR product increases the informativity of St14 VNTR for the diagnosis of hemophilia a. Disease Markers 11(2-3): 139-141
Frossard, P.M.; Newman, P.E.; Lestringant, G.G. 1994: Taqi dimorphic site in a human pancreatic phospholipase A2 (PLA2) gene localized on chromosome 12. Human Genetics 93(6): 720
Samilchuk, E.; D'Souza, B.; Voevodin, A.; Chuchalin, A.; al-Awadi, S. 1997: Taqi polymorphism in the 3' flanking region of the Pi gene among Kuwaiti Arabs and Russians. Disease Markers 13(2): 87-92
Pavlovic, M.; Kay, P.H.; Moriuchi, J.; Jacobsen, P.F.; Papadimitriou, J.M. 1993: Taqi polymorphism of the epidermal growth factor receptor gene in Caucasoids and Japanese. Human Heredity 43(1): 39-44
Jares, P.; Fernandez, P.L.; Blay, M.; Aiza, G.; Stetler-Stevenson, W.G.; Cardesa, A.; Campo, E. 1994: Taqi polymorphism of the human tissue inhibitor of metallo-proteinases-2 (Timp2) gene. Human Molecular Genetics 3(1): 218
Kellogg, D.E.; Rybalkin, I.; Chen, S.; Mukhamedova, N.; Vlasik, T.; Siebert, P.D.; Chenchik, A. 1994: TaqStart Antibody: "hot start" PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. Biotechniques 16(6): 1134-1137
Elkhadem, H.; Ibn Butlān, D. 1990: Taqwim al-Sihha (Tacuinum Sanitatis) by Ibn Butlan: the history of the text. Acta Belgica historiae medicinae: official journal of the Belgian Association for the History of Medicine 3(4): 139-146
Zimmerman, R. 2000: Tar compounds and atopic dermatitis. American Family Physician 61(11): 3252
Woitowitz, H.J. 1996: Tar particle inclusions and carcinogenesis. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 47(5): 391
Slagle, J.; Ketron, A.; Coulston, J.; Cahow, J.; Willock, K.M. 2001: Tar wars: educating today's youth about tomorrow's health. Journal of the Society of Pediatric Nurses: Jspn 6(2): 97
Negri, E.; Franzosi, M.G.; La Vecchia, C.; Santoro, L.; Nobili, A.; Tognoni, G. 1993: Tar yield of cigarettes and risk of acute myocardial infarction. GISSI-EFRIM Investigators. Bmj 306(6892): 1567-1570
Holmes, D.; Robins, M. 1992: Taranaki Board well placed to meet future challenges. New Zealand Health and Hospital 44(1): 12-18
Jordan, V. 1988: Taranaki are pleased to be an Area Health Board. New Zealand Hospital 40(4): 6-7
Sylvester, M.R.; McTavish, S.M. 1998: Taranaki community partnership model. Journal of Nursing Management 6(2): 71-75
Harding, R.; Marsh, B. 1988: Taranaki public get behind scanner appeal. New Zealand Hospital 40(4): 9; 11, 13
Mano, Y. 2001: Taranscranical magnetic stimulation (TMS) and rehabilitation medicine. Hokkaido Journal of Medical Science 76(1): 9-12
Takaoka, M.; Nakajima, S.; Sakae, H.; Nakamura, T.; Tohma, Y.; Shiono, S.; Tabuse, H. 2001: Tarantulas bite: two case reports of finger bite from Haplopelma lividum. Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 14(3): 247-250
Totten, G.; Lamb, D.H.; Reeder, G.D. 1990: Tarasoff and confidentiality in AIDS-related psychotherapy. Professional Psychology Research and Practice 21(3): 155-160
Perlin, M.L. 1992: Tarasoff and the dilemma of the dangerous patient: new directions for the 1990's. Law and Psychology Review 16: 29-63
Goldstein, R.L. 1993: Tarasoff and the practice of psychotherapy. American Journal of Psychiatry 150(8): 1278-1279
Appelbaum, P.S.; Rosenbaum, A. 1989: Tarasoff and the researcher: does the duty to protect apply in the research setting?. American Psychologist 44(6): 885-894
Herbert, P.B.; Young, K.A. 2002: Tarasoff at twenty-five. Journal of the American Academy of Psychiatry and the Law 30(2): 275-281
Mendelson, D.; Mendelson, G. 1991: Tarasoff down under: the psychiatrist's duty to warn in Australia. Journal of Psychiatry and Law 19(1-2): 33-61
Reilly, P. 1980: When should an investigator share raw data with the subjects?. Irb 2(9): 4-5+
Felthous, A.R.; Scarano, V.R. 1999: Tarasoff in Texas. Texas Medicine 95(3): 72-78
Truscott, D.; Crook, K.H. 1993: Tarasoff in the Canadian context: Wenden and the duty to protect. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 38(2): 84-89
Mason, T. 1998: Tarasoff liability: its impact for working with patients who threaten others. International Journal of Nursing Studies 35(1-2): 109-114
Balon, R.; Mufti, R. 1997: Tarasoff ruling and reporting to the authorities. American Journal of Psychiatry 154(9): 1321
Valentine, G.H. 1975: Tarasoff v. Regents of University of California: the psychotherapist's peril. University of Pittsburgh law review. University of Pittsburgh. School of Law 37(1): 155-168
Lowe, R.H. 1975: Tarasoff v. Regents of the University of California--risk allocation in mental health care: whether to treat the patient or his victim. Utah law review 1975(2): 553-569
Anonymous 1976: Tarasoff v. Regents of the University of California. 1 Jul 1976. West's California Reporter 131: 14-42
Anonymous 1974: Tarasoff v. Regents of the University of California. 23 Dec 1974. West's California Reporter 118: 129-145
Anonymous 1973: Tarasoff v. Regents of the University of California. 6 Jul 1973. West's California Reporter 108: 878-901
Nesbitt, N.A. 1977: Tarasoff v. Regents of the University of California: psychotherapist's obligation of confidentiality versus the duty to warn. Tulsa law journal 12(4): 747-757
Kaplan, R.B. 1975: Tarasoff v. Regents of the University of California: psychotherapists, policemen and the duty to warn--an unreasonable extension of the common law?. Golden Gate law review 6(1): 229-248
Cohen, R.N. 1978: Tarasoff v. Regents of the University of California: the duty to warn--common law and statutory problems for California psychotherapists. California Western law review 14(1): 153-182
Leeman, C.P. 2000: Tarasoff warnings. Psychiatric Services 51(10): 1318
Givelber, D.J.; Bowers, W.J.; Blitch, C.L. 1984: Tarasoff, myth and reality: an empirical study of private law in action. Wisconsin law review 1984(2): 443-497
Schopp, R.F.; Quattrocchi, M.R. 1984: Tarasoff, the doctrine of special relationships, and the psychotherapist's duty to warn. Journal of Psychiatry and Law 12(1): 13-37
Knapp, S.; Vandecreek, L. 1982: Tarasoff: five years later. Professional Psychology 13(4): 511-515
Zwas, D.R.; Takuma, S.; Mullis-Jansson, S.; Fard, A.; Chaudhry, H.; Wu, H.; Di Tullio, M.R.; Homma, S. 1999: Feasibility of real-time 3-dimensional treadmill stress echocardiography. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography 12(5): 285-289
Billodeaux, D.R.; Benavides, G.A.; Fischer, N.H.; Fronczek, F.R. 1999: Taraxerol acetate at 100 K. Acta Crystallographica. Section C Crystal Structure Communications 55: 2129-2131
Goldstein, B.; Blaxter, M. 2002: Tardigrades. Current Biology: Cb 12(14): R475
Tarsy 2000: Tardive Dyskinesia. Current Treatment Options in Neurology 2(3): 205-214
Malek-Ahmadi, P.; Weddige, R.L.. 1988: Tardive Dyskinesia and Electroconvulsive Therapy. Convulsive Therapy 4(4): 328-331
Sachdev, P. 1994: Tardive akathisia, tardive dyskinesia, and serum iron status. Journal of Clinical Psychopharmacology 14(2): 147-149
Sachdev, P. 1993: Tardive and chronically recurrent oculogyric crises. Movement Disorders: Official Journal of the Movement Disorder Society 8(1): 93-97
Sachdev, P. 1998: Tardive blepharospasm. Movement Disorders: Official Journal of the Movement Disorder Society 13(6): 947-951
Burn, D.J.; Coulthard, A.; Connolly, S.; Cartlidge, N.E. 1998: Tardive diaphragmatic flutter. Movement Disorders: Official Journal of the Movement Disorder Society 13(1): 190-192
Baribeau, J.; Laurent, J.P.; Décary, A. 1993: Tardive dyskinesia and associated cognitive disorders: a convergent neuropsychological and neurophysiological approach. Brain and Cognition 23(1): 40-55
Swartz, J.R.; Burgoyne, K.; Smith, M.; Gadasally, R.; Ananth, J.; Ananth, K. 1997: Tardive dyskinesia and ethnicity: review of the literature. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 9(1): 53-59
Chong, S.-A.; Mythily; Lum, A.; Huak, C.Y.; Kane, J. 2002: Tardive dyskinesia and impaired glucose tolerance. Human Psychopharmacology 17(6): 305-307
Ondo, W.G.; Hurwitz, B.J. 1993: Tardive dyskinesia and pseudo-parkinsonism. in a nursing home patient who itched. North Carolina Medical Journal 54(11): 605-607
Nomoto, M. 2000: Tardive dyskinesia and the therapeutic agents. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 115(3): 171-174
Wright, P.; Taylor, M. 1994: Tardive dyskinesia as a risk factor for negative symptoms. British Journal of Psychiatry: the Journal of Mental Science 164(5): 700
Sandler, N.H. 1996: Tardive dyskinesia associated with fluoxetine. Journal of Clinical Psychiatry 57(2): 91
Herrán, A.; Vázquez-Barquero, J.L. 1999: Tardive dyskinesia associated with olanzapine. Annals of Internal Medicine 131(1): 72
Ananth, J.; Kenan, J. 1999: Tardive dyskinesia associated with olanzapine monotherapy. Journal of Clinical Psychiatry 60(12): 870
Spivak, M.; Smart, M. 2000: Tardive dyskinesia from low-dose risperidone. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 45(2): 202
Snoddgrass, P.L.; Labbate, L.A. 1999: Tardive dyskinesia from risperidone and olanzapine in an alcoholic man. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(9): 921
Chong, S.A. 1997: Tardive dyskinesia in CYP2D6 polymorphism in Chinese. British Journal of Psychiatry: the Journal of Mental Science 171: 586
Meyer-Lindenberg, A.; Krausnick, B. 1997: Tardive dyskinesia in a neuroleptic-naive patient with bipolar-i disorder: persistent exacerbation after lithium intoxication. Movement Disorders: Official Journal of the Movement Disorder Society 12(6): 1108-1109
Pandurangi, A.K.; Aderibigbe, Y.A. 1995: Tardive dyskinesia in non-western countries: a review. European Archives of Psychiatry and Clinical Neuroscience 246(1): 47-52
Woerner, M.G.; Sheitman, B.B.; Lieberman, J.A.; Kane, J.M. 1996: Tardive dyskinesia induced by risperidone?. American Journal of Psychiatry 153(6): 843
Klintenberg, R.; Gunne, L.; Andrén, P.E. 2002: Tardive dyskinesia model in the common marmoset. Movement Disorders: Official Journal of the Movement Disorder Society 17(2): 360-365
Russo, D.T.; Bunch, C.L. 1995: Tardive dyskinesia revisited. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 52(19): 2137-2138
Ghelber, D.; Belmaker, R.H. 1999: Tardive dyskinesia with quetiapine. American Journal of Psychiatry 156(5): 796-797
Preradović, M.; Ilić, T.; Bjelica, N. 1996: Tardive dyskinesia with special emphasis on tardive dyskinesia caused by neuroleptics. Vojnosanitetski Pregled 53(6): 519-526
Peet, M.; Laugharne, J.; Rangarajan, N.; Reynolds, G.P. 1993: Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin e treatment. International Clinical Psychopharmacology 8(3): 151-153
Akbostanci, M.C.; Atbaşoğlu, E.C.; Balaban, H. 1999: Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution. Acta Neurologica Belgica 99(3): 176-181
Kazamatsuri, H. 1993: Tardive dyskinesia--diagnosis and treatment. Nihon Rinsho. Japanese Journal of Clinical Medicine 51(11): 2972-2977
Lauterbach, E.C.; Carter, W.G.; Rathke, K.M.; Thomas, B.H.; Shillcutt, S.D.; Vogel, R.L.; Moore, N.C.; Mimbs, J.W.; Nelson, W.H. 2001: Tardive dyskinesia--diagnostic issues, subsyndromes, and concurrent movement disorders: a study of state hospital inpatients referred to a movement disorder consultation service. Schizophrenia Bulletin 27(4): 601-613
Lazarus, A. 1994: Tardive dyskinesia-like syndrome associated with lithium and carbamazepine. Journal of Clinical Psychopharmacology 14(2): 146-147
Gersten, S.P. 1993: Tardive dyskinesia-like syndromes with clomipramine. American Journal of Psychiatry 150(1): 165-166
Latimer, P.R. 1995: Tardive dyskinesia: a review. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 40(7 Suppl 2: S49-S54
Najib, J. 1999: Tardive dyskinesia: a review and current treatment options. American Journal of Therapeutics 6(1): 51-60
Jessurun, A.Y.; Stek, M.L. 1995: Tardive dyskinesia: an increased risk of neuroleptics in elderly women. Tijdschrift Voor Gerontologie en Geriatrie 26(5): 197-199
Furer, V.; Lichtenberg, P.; Heresco-Levy, U. 2001: Tardive dyskinesia: etiology, clinical features and therapy. Harefuah 140(3): 248-252
Slaw, K.M.; Kalachnik, J.E. 1985: Tardive dyskinesia: facts the mental health administrator may not know. Journal of Mental Health Administration 12(2): 22-27
Taub, S. 1986: Tardive dyskinesia: medical facts and legal fictions. Saint Louis University Law Journal 30(3): 833-875
Elkashef, A.M.; Wyatt, R.J. 1999: Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin e. Schizophrenia Bulletin 25(4): 731-740
Gattaz, W.F.; Gerlach, J. 1993: Tardive dyskinesia: preclinical and clinical aspects. European Archives of Psychiatry and Clinical Neuroscience 243(2): 116-118
Gupta, S.; Mosnik, D.; Black, D.W.; Berry, S.; Masand, P.S. 1999: Tardive dyskinesia: review of treatments past, present, and future. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 11(4): 257-266
Kaye, N.S.; Reed, T.J. 1999: Tardive dyskinesia: tremors in law and medicine. Journal of the American Academy of Psychiatry and the Law 27(2): 315-333
Kalachnik, J.E.; Slaw, K.M. 1986: Tardive dyskinesia: update for the mental health administrator. Journal of Mental Health Administration 13(2): 1-8
Fabbrini, G.; Barbanti, P.; Aurilia, C. 2001: Tardive dyskinesias in the elderly. International Journal of Geriatric Psychiatry 16(Suppl 1): S19-S23
Sempere, A.P.; Mola, S.; Flores, J. 1997: Tardive dystonia following the administration of clebopride. Revista de Neurologia 25(148): 2060
Krebs, M.O.; Olie, J.P. 1999: Tardive dystonia induced by risperidone. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(5): 507-508
Rowley, H.; Lynch, T.; Keogh, I.; Russell, J. 2001: Tardive dystonia of the larynx in a quadriplegic patient: an unusual cause of stridor. Journal of Laryngology and Otology 115(11): 918-919
Ebersbach, G.; Tracik, F.; Wissel, J.; Poewe, W. 1997: Tardive jaw tremor. Movement Disorders: Official Journal of the Movement Disorder Society 12(3): 460-462
Raja, M.; Maisto, G.; Altavista, M.C.; Albanese, A. 1996: Tardive lingual dystonia treated with clozapine. Movement Disorders: Official Journal of the Movement Disorder Society 11(5): 585-586
Dave, M. 1994: Tardive oculogyric crises with clozapine. Journal of Clinical Psychiatry 55(6): 264-265
Porcu, A.; Dessanti, A.; Scanu, A.M.; Feo, C.F.; Cocco, L.; Dettori, G. 1998: Tardive presentation of congenital cystic adenomatoid malformation of the lung. Minerva Chirurgica 53(6): 553-556
Matteucci, C.; Busi, G.; Biferali, F.; Paventi, S. 1997: Tardive pseudo-ischemic presentation of cardiac rhabdomyoma. Giornale Italiano di Cardiologia 27(6): 583-587
Bharucha, K.J.; Sethi, K.D. 1995: Tardive tourettism after exposure to neuroleptic therapy. Movement Disorders: Official Journal of the Movement Disorder Society 10(6): 791-793
Storey, E.; Lloyd, J. 1997: Tardive tremor. Movement Disorders: Official Journal of the Movement Disorder Society 12(5): 808-810
Tarsy, D.; Indorf, G. 2002: Tardive tremor due to metoclopramide. Movement Disorders: Official Journal of the Movement Disorder Society 17(3): 620-621
Ballesio, L.; Angeli, M.L.; Carrozza, C.; Manganaro, L. 2002: Tardive "lipophagic granuloma" studied by mammography, color-Doppler sonography and magnetic resonance imaging: a case report. La Radiologia Medica 104(1-2): 102-105
McLeary, M.S.; Rouse, G.A. 1996: Tardus-parvus Doppler signals in the renal arteries: a sign of pediatric thoracoabdominal aortic coarctations. Ajr. American Journal of Roentgenology 167(2): 521-523
Emmitt, R.J. 1993: Tardy compassion. Lancet 341(8853): 1157-1158
Weisman, D.S.; Rang, M.; Cole, W.G. 1999: Tardy displacement of traumatic radial head dislocation in childhood. Journal of Pediatric Orthopedics 19(4): 523-526
Chang, C.W.; Lien, I.N. 1994: Tardy effect of neurogenic muscular atrophy by magnetic stimulation. American Journal of Physical Medicine and Rehabilitation 73(4): 275-279
Spinner, R.J.; Spinner, M. 1997: Tardy posterior interosseous nerve palsy due to childhood osteomyelitis: a case report. Journal of Hand Surgery 22(6): 1049-1051
O'Driscoll, S.W.; Spinner, R.J.; McKee, M.D.; Kibler, W.B.; Hastings, H.; Morrey, B.F.; Kato, H.; Takayama, S.; Imatani, J.; Toh, S.; Graham, H.K. 2001: Tardy posterolateral rotatory instability of the elbow due to cubitus varus. Journal of Bone and Joint Surgery. American Volume 83(9): 1358-1369
Saitoh, S.; Seki, H.; Murakami, N.; Hata, Y.; Takaoka, K. 2000: Tardy ulnar tunnel syndrome caused by Galeazzi fracture-dislocation: a neuropathy with a new pathomechanism. Journal of Orthopaedic Trauma 14(1): 66-70
Grieve, R.A. 1997: Target Earth: evidence for large-scale impact events. Annals of the new York Academy of Sciences 822: 319-352
Odama, U.; Bakris, G. 2000: Target Organ Damage in Hypertension. Journal of Clinical Hypertension 2(5): 312-318
Lindemuth; Reinovsky; Chrien; Christian; Ekdahl; Goforth; Haight; Idzorek; King; Kirkpatrick; Larson; Morgan; Olinger; Oona; Sheehey; Shlachter; Smith; Veeser; Warthen; Younger; Chernyshev; Mokhov; Demin; Dolin; Garanin; Ivanov; Korchagin; Mikhailov; Morozov; Pak; Pavlovskii; Seleznev; Skobelev; Volkov; Yakubov 1995: Target Plasma Formation for Magnetic Compression/Magnetized Target Fusion. Physical Review Letters 75(10): 1953-1956
Robra, B.P.; Swart, E.; Klas, P.; Leber, W.D. 1998: Target agreements between insurance carriers and hospitals as instrument for modifying hospital length of stay. Gesundheitswesen 60(4): 211-216
Raghavan, S.; Rajender, A. 2002: Target alcohol/phenol release by cyclative cleavage using glycine as a safety catch linker. Chemical Communications 15: 1572-1573
Quaglia, M.; Chenon, K.; Hall, A.J.; De Lorenzi, E.; Sellergren, B. 2001: Target analogue imprinted polymers with affinity for folic acid and related compounds. Journal of the American Chemical Society 123(10): 2146-2154
Piñón, L.G.; Linden, R. 1996: Target and afferents interact to control developmental cell death in the mesencephalic parabigeminal nucleus of the rat. Journal of Neuroscience Research 45(2): 174-182
Galster; Leleux; Licot; Lienard; Lipnik; Mertens; Delbar; Vervier; Decrock; Huyse; Van Duppen P; Duhamel; Vanhorenbeeck; Roters; Rolfs; Schroeder; Trautvetter; Wolke; Lambert; Rodney 1991: Target and detection techniques for the 13N(p, gamma )14O reaction using radioactive ion beams: 13C(p, gamma )14N reaction as a test case. Physical Review. C Nuclear Physics 44(6): 2776-2787
Shivpuri; Parashar 1994: Target and energy dependence of intermittency and multifractality in interactions at cosmic ray energies. Physical Review. D Particles and Fields 49(1): 219-229
Cook; Abdallah; Stephens; Kemper 1987: Target and projectile excitation of 7Li. Physical Review. C Nuclear Physics 35(1): 126-136
Singh; Jain 1996: Target and projectile fragmentations in 208Pb-emulsion collisions at 160A GeV. Physical Review. C Nuclear Physics 54(6): 3185-3194
Vanoverschelde, J.L. 2002: Target and therapeutic microbubbles. Annales de Cardiologie et d'Angeiologie 51(4): 223-224
Saffran, D.C.; Reiter, R.E.; Jakobovits, A.; Witte, O.N. 1999: Target antigens for prostate cancer immunotherapy. Cancer Metastasis Reviews 18(4): 437-449
Dionisi, S.; Dotta, F.; Diaz-Horta, O.; Carabba, B.; Viglietta, V.; Di Mario, U. 1997: Target antigens in autoimmune diabetes: pancreatic gangliosides. Annali Dell'istituto Superiore di Sanita 33(3): 433-435
Tabira, T. 1994: Target antigens in neuroimmunological diseases. Nihon Rinsho. Japanese Journal of Clinical Medicine 52(11): 2855-2860
Calmus, Y.; Ayani, E.; Cardoso, J.; Chéreau, C.; Kahan, A.; Houssin, D.; Weill, B. 1993: Target antigens of hyperacute xenogeneic rejection in the rat to guinea pig to rat discordant combinations. Transplantation 56(4): 778-785
Ohashi; Awaji; Hayashii; Horikawa; Miyamoto; Nakanishi; Okumi; Ozaki; Tauchi; Ishii; Kato; Okuno; Ukai; Mori; Takeuchi 1987: Target asymmetry measurement in gamma d-->. Physical Review. C Nuclear Physics 36(6): 2422-2435
Hebert, L.A. 1999: Target blood pressure for antihypertensive therapy in patients with proteinuric renal disease. Current Hypertension Reports 1(5): 454-460
Klein, W. 1999: Target blood pressure values from the cardiologic viewpoint. Wiener Medizinische Wochenschrift 149(23-24): 625-628
Schrader, J. 1997: Target blood pressure with antihypertensive therapy and 24-hour-RR measurement. Fortschritte der Medizin 115(28): 26 29-30 33-4
Wolf, H.; Freimann, U.; Jung, G. 1994: Target cell induced T cell activation with bispecific antibodies: a new concept for tumor immunotherapy. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 135: 185-195
Thorgeirsson, S.S. 1995: Target cell populations in virus-associated hepatocarcinogenesis. Princess Takamatsu Symposia 25: 163-170
Artrip, J.H.; Kwiatkowski, P.; Michler, R.E.; Wang, S.F.; Tugulea, S.; Ankersmit, J.; Chisholm, L.; McKenzie, I.F.; Sandrin, M.S.; Itescu, S. 1999: Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)-galactosyltransferase and reduced by alpha(1, 2)-fucosyltransferase. Journal of Biological Chemistry 274(16): 10717-10722
Taga, K.; Yamauchi, A.; Bloom, E.T. 1999: Target cell-induced apoptosis in IL-2-activated human natural killer cells. Leukemia and Lymphoma 32(5-6): 451-458
Kurimura, T. 1993: Target cells for HIV and the mechanism of its penetration into the cells. Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 73-75
Lindhe, O.; Granberg, L.; Brandt, I. 2002: Target cells for cytochrome p450-catalysed irreversible binding of 7,12-dimethylbenz[a]anthracene (DMBA) in rodent adrenal glands. Archives of Toxicology 76(8): 460-466
Bahrami, F.; van Hezik, C.; Bergman, A.; Brandt, I. 2000: Target cells for methylsulphonyl-2,6-dichlorobenzene in the olfactory mucosa in mice. Chemico-Biological Interactions 128(2): 97-113
Zhang, T.; Shen, Y.-p.; Liu, Y.; Yang, W.-p.; Shao, J.-o.; Ju, S.-y.; Dong, K.; Xu, J.-l.; Jiang, J.-m. 2002: Target chemotherapy of intestinal nematode infection in area with low endemicity. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 20(3): 174-176
Anonymous 1994: Target community foundations to fund family planning. Contraceptive Technology Update 15(4): 50-53
Smith, D.M.; Neuberg, S.L.; Judice, T.N.; Biesanz, J.C. 1997: Target complicity in the confirmation and disconfirmation of erroneous perceiver expectations: immediate and longer-term implications. Journal of Personality and Social Psychology 73(5): 974-991
Holford, N.H. 1999: Target concentration intervention: beyond Y2K. British Journal of Clinical Pharmacology 48(1): 9-13
Kazanikova, A.N.; Likhvantsev, V.V.; Subbotin, V.V. 2002: Target control infusion of propofol: is this method really preferable?. Anesteziologiia i Reanimatologiia 3: 41-44
Ecoffey, C.; Viviand, X.; Billard, V.; Cazalaà, J.B.; Molliex, S.; Servin, F.; Laxenaire, M.C. 2001: Target controlled infusion (TCI) anesthesia using propofol. Assessment of training and practice in the operating room. Annales Francaises d'Anesthesie et de Reanimation 20(3): 228-245
Schraag, S.; Flaschar, J.; Georgieff, M. 2000: Target controlled infusion (TCI)--status and clinical perspectives. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie: Ains 35(1): 12-20
Cavaliere, F.; Pennisi, M.A.; Meo, F.; De Cosmo, G.; La Mura, F.; Proietti, R. 1999: Target controlled infusion (TCI): applications of the "TCI visual" program in anesthesia and sedation with propofol. Minerva Anestesiologica 65(12): 849-858
Varveris, D.A.; Morton, N.S. 2002: Target controlled infusion of propofol for induction and maintenance of anaesthesia using the paedfusor: an open pilot study. Paediatric Anaesthesia 12(7): 589-593
Mertens, E.; Saldien, V.; Coppejans, H.; Bettens, K.; Vercauteren, M. 2001: Target controlled infusion of remifentanil and propofol for cesarean section in a patient with multivalvular disease and severe pulmonary hypertension. Acta Anaesthesiologica Belgica 52(2): 207-209
Vermeyen, K.M.; Hoffmann, V.L.; Saldien, V.; Adriaensen, H.F. 2002: Target controlled infusion of rocuronium: selection of a pharmacokinetic model. Acta Anaesthesiologica Belgica 53(1): 17-19
Servin, F. 1999: Target controlled infusions in children and elderly patients. Acta Anaesthesiologica Belgica 50(4): 183-186
Yeh, M.; Wickens, C.D.; Seagull, F.J. 1999: Target cuing in visual search: the effects of conformality and display location on the allocation of visual attention. Human Factors 41(4): 524-542
Kollias, S.S.; Bernays, R.; Marugg, R.A.; Romanowski, B.; Yonekawa, Y.; Valavanis, A. 1998: Target definition and trajectory optimization for interactive MR-guided biopsies of brain tumors in an open configuration MRi system. Journal of Magnetic Resonance Imaging: Jmri 8(1): 143-159
Guo, W.Y.; Nordell, B.; Karlsson, B.; Söderman, M.; Lindqvist, M.; Ericson, K.; Franck, A.; Lax, I.; Lindquist, C. 1993: Target delineation in radiosurgery for cerebral arteriovenous malformations. Assessment of the value of stereotaxic MR imaging and MR angiography. Acta Radiologica 34(5): 457-463
Krivtsov, G.G.; Zhdanov, R.I. 2000: Target delivery of functional genes in gene therapy using carbohydrate containing vectors. Voprosy Meditsinskoi Khimii 46(3): 246-255
Hsu 1991: Target dependence for the quadrupole shape parameter of electrons captured to the continuum in 30-keV proton collisions with He, Ne, and Ar. Physical Review. A Atomic Molecular and Optical Physics 43(3): 1618-1620
Jiang; Ernst; Chen 1995: Target dependence of K+-nucleus total cross sections. Physical Review. C Nuclear Physics 51(2): 857-864
Pan; Starace 1991: Target dependence of angular distributions for near-threshold (e,2e) processes. Physical Review Letters 67(2): 185-188
Andersen; Barnes; Blaes; Braun; Brom; Castaño; Cherney; Cohler; de la Cruz B; Diebold; Fernández; Franklin; Garabatos; Garzón; Geist; Greiner; Gruhn; Hafidouni; Hrubec; Huss; Jacquot; Jones; Kuipers; Ladrem; Ladrón de Guevara P; Liko; Lopez-Ponte; Lovhoiden; MacNaughton; Maher; Michalon; Michalon-Mentzer; Mosquera; Natkaniec; Nelson; Neuhofer; Perez de los Heros C; Pló; Porth; Powell; Quinn; Ramil; Riester; Rohringer; Sakrejda; Sakrejda; Thorsteinsen; Traxler; Voltolini; Yañez; Yepes; Zybert 1992: Target dependence of central rapidity Lambda production in sulfur-nucleus collisions at 200 GeV/c per nucleon. Physical Review. C Nuclear Physics 46(2): 727-735
Shivpuri; Verma 1993: Target dependence of intermittency and multifractality of multiplicity fluctuations in 800-GeV proton emulsion-nuclei interactions. Physical Review. D Particles and Fields 47(1): 123-132
Cohen; Leon 1986: Target dependence of the effective sticking probability in muon-catalyzed d-t fusion. Physical Review. a General Physics 33(2): 1437-1439
Ernfors, P.; Lee, K.F.; Jaenisch, R. 1994: Target derived and putative local actions of neurotrophins in the peripheral nervous system. Progress in Brain Research 103: 43-54
Richer, F.; Décary, A.; Lapierre, M.F.; Rouleau, I.; Bouvier, G.; Saint-Hilaire, J.M. 1993: Target detection deficits in frontal lobectomy. Brain and Cognition 21(2): 203-211
Spence, I.; Efendov, A. 2001: Target detection in scientific visualization. Journal of Experimental Psychology. Applied 7(1): 13-26
Hettinger, L.J.; Nelson, W.T.; Haas, M.W. 1996: Target detection performance in helmet-mounted and conventional dome displays. International Journal of Aviation Psychology 6(4): 321-334
Pitt, B.; Nicklas, J.M. 1998: Target doses of ACE inhibitors in heart failure: where should we aim?. European Heart Journal 19(3): 370-371
Cionga; Florescu; Maquet; Taïeb 1993: Target dressing effects in laser-assisted x-ray photoionization. Physical Review. A Atomic Molecular and Optical Physics 47(3): 1830-1840
Chrymko, M.M.; Meyer, J.D.; Kelly, W.N. 1994: Target drug monitoring: a cost-effective service provided by staff pharmacists. Hospital Pharmacy 29(4): 347; 350-352
Baum, N. 1999: Target educated patients. Hospital Peer Review 24(6): 91-93
Paleolog, E. 1997: Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis. Molecular Pathology: Mp 50(5): 225-233
Hustedt; Freese; Mähl; Heiland; Schippers; Bleck-Neuhaus; Grether; Köhrbrück; Stolterfoht 1994: Target effects in the interaction of highly charged Ne ions with an Al(110) surface. Physical Review. A Atomic Molecular and Optical Physics 50(6): 4993-4999
McConnell, A.R.; Sherman, S.J.; Hamilton, D.L. 1997: Target entitativity: implications for information processing about individual and group targets. Journal of Personality and Social Psychology 72(4): 750-762
Majka; Abenante; Li; Nicolis; Sarantites; Semkow; Sobotka; Stracener; Beene; Hensley; Griffin 1989: Target excitation and angular momentum transfer in reactions of E/A=11.9 MeV 28Si with 181Ta from 4 pi charged particle, neutron, and gamma -ray multiplicity measurements. Physical Review. C Nuclear Physics 40(5): 2124-2136
Quintana; Andriamasy; Schneider; Pollack 1989: Target excitation in H2++He collisions. Physical Review. A General Physics 39(10): 5045-5047
Sahota, R.S.; Khaledi, M.G. 1994: Target factor modeling of migration behavior in capillary electrophoresis. Analytical Chemistry 66(14): 2374-2381
Barbara, T.M.; Bronnimann, C.E. 1999: Target field design for magic angle gradient coils. Journal of Magnetic Resonance 140(1): 285-288
Nielsen, A.M.; Madsen, J.R. 1994: Target for anti-ulcer agents--pH, H. pylori or NO?. Nordisk Medicin 109(3): 81-83
Reid, A. 2002: Target format and hybridization conditions. Methods in Molecular Biology 179: 1-11
Loveland; Hellström; Sihver; Aleklett 1990: Target fragment mass distribution for the reaction of 13.3 GeV/nucleon 28Si with 197au. Physical Review. C Nuclear Physics 42(4): 1753-1756
Sümmerer; Brüchle; Morrissey; Schädel; Szweryn; Yang 1990: Target fragmentation of au and Th by 2.6 GeV protons. Physical Review. C Nuclear Physics 42(6): 2546-2561
Bronikowski; Porile 1991: Target fragmentation of silver by 14.6 GeV/nucleon 16O ions. Physical Review. C Nuclear Physics 44(4): 1661-1664
Wenxin; Tongyu; Tahai; Yunsheng; Yuming; Ruling; Lili; Dingqing; Genming; Benhao 1993: Target fragments from the interaction of 93Nb and 181Ta with 47 MeV/nucleon 12C ions. Physical Review. C Nuclear Physics 48(2): 628-632
Dudkin, V.E.; Kovalev, E.E.; Nefedov, N.A.; Antonchik, V.A.; Bogdanov, S.D.; Ostroumov, V.I.; Benton, E.V.; Crawford, H.J.; Benton, E.V. 1991: Target fragments in collisions of 1.8 GeV/nucleon 56Fe nuclei with photoemulsion nuclei, and the cascade-evaporation model. Nuclear Physics. a 530: 759-769
Rivacoba, A.; Aizpurua, J.; Zabala, N. 1995: Target geometry dependence of electron energy loss spectra in scanning transmission electron microscopy (STEM). Scanning Microscopy 9(4): 927
Garg, M.K.; Tandon, N.; Gupta, N.; Varma, A.; Singh, V.P. 2001: Target gland functional status in patients with non-Cushing's pituitary macroadenomas undergoing transsphenoidal microsurgery. Journal of the Association of Physicians of India 49: 221-226
Nissenson, A.R.; Besarab, A.; Bolton, W.K.; Goodkin, D.A.; Schwab, S.J. 1997: Target haematocrit during erythropoietin therapy. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 12(9): 1813-1816
Vlassopoulos, D.; Sonikian, M.; Dardioti, V.; Hadjiconstantinou, V. 1999: Target haematocrit during erythropoietin treatment in dialysis patients. which value is 'true-functional haematocrit'?. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(5): 1340-1341
Morizuki, O.; Kawauchi, M.; Furuse, A. 1994: Target heart rate for exercise echocardiography. Journal of Cardiology 24(3): 199-202
Johnson, L. 1997: Caring by example builds your facility's business. Balance 1(3): 22; 31
Fiesta, J. 1998: Target high-risk areas for medication errors. Nursing Management 29(12): 12-13
Anonymous 1998: Target individual needs to boost diabetic compliance. Hospital case management: the monthly update on hospital-based care planning and critical paths 6(2): 35-39
Tanis; Bernstein; Clark; Ferguson; Price 1991: Target ionization accompanied by projectile electron loss in fast O6,7++He collisions. Physical Review. a Atomic Molecular and Optical Physics 43(9): 4723-4726
Rubins, H.B. 1994: Target levels for low-density lipoprotein in patients with coronary heart disease. JAMA 271(2): 101-102
Niemelä, R.I.; Rantanen, J.; Kiilunen, M.K. 1998: Target levels--tools for prevention. Risk Analysis: An Official Publication of the Society for Risk Analysis 18(6): 679-688
Saarinen, J. 1996: Target localisation and identification in rapid visual search. Perception 25(3): 305-311
Verellen, D.; Linthout, N.; Storme, G. 1998: Target localization and treatment verification for intensity modulated conformal radiation therapy of the head and neck region. the AZ-VUB experience. Akademisch Ziekenhuis-Vrije Universiteit Brussel. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 174(Suppl 2): 19-27
Bel, A.; van Herk, M.; Lebesque, J.V. 1996: Target margins for random geometrical treatment uncertainties in conformal radiotherapy. Medical Physics 23(9): 1537-1545
Anonymous 1988: Target market: arthritis. Packaging services creates new arthritis center. Profiles in healthcare marketing 1988(32): 76-79
Anonymous 1988: Target market: diabetes. Profiles in healthcare marketing 1988(31): 46-49
Cangelosi, J.D. 1997: Target marketing for the hospital-based wellness center. Journal of Hospital Marketing 11(2): 61-80
Berry, L. 1987: Target marketing to elderly. Texas Hospitals 42(11): 13-14
Kiss; Deák; Seres; Caskey; Galonsky; Heilbronn; Remington 1988: Target mass dependence of neutron emission in collisions with 35 MeV/nucleon 14N ions. Physical Review. C Nuclear Physics 38(1): 170-178
Tagliabue, E.; Pilotti, S.; Gianni, A.M.; Ménard, S.; Colnaghi, M.I. 1998: Target molecules for immunotherapy of inflammatory breast carcinomas. European Journal of Cancer 34(12): 1982-1983
Sugimoto, K. 2001: Target molecules of anti-tumor drugs and cell checkpoints. Japanese Journal of Clinical Hematology 42(5): 356-358
Clarke, N. 2002: Target morphologies via a two-step dissolution-quench process in polymer blends. Physical Review Letters 89(21): 215506
Hricik, D.E. 2001: Target of rapamycin (TOR) inhibition in renal transplantation: Clinical uses in various populations. Introduction. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 38(4 Suppl. 2): S1-S2
Dennis, P.B.; Fumagalli, S.; Thomas, G. 1999: Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Current Opinion in Genetics and Development 9(1): 49-54
Germinario, C.; Lopalco, P.L.; Prato, R.; Quarto, M. 2002: Target of the anti-varicella vaccine. Annali di Igiene: Medicina Preventiva e di Comunita 14(4 Suppl 6: 55-58
Suzuki, T.; Itoh, S.; Nakajima, M.; Hachiya, N.; Hara, T. 1999: Target organ and time-course in the mutagenicity of five carcinogens in MutaMouse: a summary report of the second collaborative study of the transgenic mouse mutation assay by JEMS/MMS. Mutation Research 444(2): 259-268
Palatini; Canali; Dorigatti; Baccillieri; Giovinazzo; Roman; Mormino; Visentin; Berton; Catania; Gregori; Santonastaso; Piccolo; Garavelli; Pegoraro; D'Este; Maraglino; Martines; Businaro; Cignacco; Zanata; Gelisio; Mattarei; Biasion; Zonzin; Bortolazzi; Ferrarese; Mos; Ovan; Vriz; Graniero; Milani; Devenuto; Dal Follo M; Gatti; Camarotto; Stritoni; Perissinotto; Sanzuol; Cozzutti; Mognol; Pessina 1997: Target organ damage and ambulatory blood pressure in stage I hypertension. The Hypertension and Ambulatory Recording Venetia Study. Blood Pressure Monitoring 2(2): 79-88
Fabbian, F.; Cavallini, A.R.; Caló, G.; Bagni, B.; Gilli, P.; Squerzanti, R. 1997: Target organ damage and renin-angiotensin-aldosterone system in essential hypertensives with and without metabolic risk factors. Clinical Nephrology 47(2): 137-138
O'Rourke, M. 2002: Target organ damage: use of pulse wave analysis as a manifestation of aortic degeneration in the assessment of hypertension. Vascular Medicine 7(2): 83-85
Jones, J.A.; Brown, E.J.; Volicer, L. 2000: Target outcomes for long-term oral health care in dementia: a Delphi approach. Journal of Public Health Dentistry 60(4): 330-334
Giuffrida, A.; Gosden, T.; Forland, F.; Kristiansen, I.S.; Sergison, M.; Leese, B.; Pedersen, L.; Sutton, M. 2000: Target payments in primary care: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 3: Cd000531
Boissel, J.P. 1997: Target population for hypertensive therapy. Archives des Maladies du Coeur et des Vaisseaux 90(Special Issue 5): 31-34
Anonymous 2000: Target population growth: zero. China population today 17(1): 19
Pentz, M.A. 1994: Target populations and interventions in prevention research: what is high risk?. Nida Research Monograph 139: 75-93
Moore, A. 1998: Target practice. Nursing Standard: 1987) 12(35): 24-25
Lewin, M.E. 1999: Target practice over healthcare issues. Journal of Medical Practice Management: Mpm 15(3): 117-118
Dobson, J.; Wilson, D. 1991: Target practice puts managers in Sir Donald's firing line. Health Service Journal 101(5277): 31-32
Novarro, L. 1996: Target practice. In California and elsewhere, state officials are taking shots at hospital sales to for-profits. Hospitals and Health Networks 70(24): 16-17
Gesink, J. 1999: Target practice: a BMET's guide to accuracy, precision and resolution. Biomedical Instrumentation and Technology 33(5): 427-430
Caprioli, J. 2001: Target pressure. Ophthalmology 108(8): 1367-1368
Muñoz Negrete, F.J. 2002: Target pressure evidences. Archivos de la Sociedad Espanola de Oftalmologia 77(11): 587-588
Jampel, H.D. 1997: Target pressure in glaucoma therapy. Journal of Glaucoma 6(2): 133-138
Singh, K.; Spaeth, G.; Zimmerman, T.; Minckler, D. 2000: Target pressure--glaucomatologists' holey grail. Ophthalmology 107(4): 629-630
Yoshikawa, K. 2002: Target pressure: can target be a nugget?. Nippon Ganka Gakkai Zasshi 106(8): 459-460
Zeyen, T. 1999: Target pressures in glaucoma. Bulletin de la Societe Belge d'Ophtalmologie 274: 61-65
Jasch, F.; Blumen, A. 2001: Target problem on small-world networks. Physical Review. E Statistical Nonlinear and Soft Matter Physics 63(4 Part 1): 041108
Vedani, A.; Zbinden, P. 1997: Target proteins and mechanisms of ochratoxin toxicity. a contribution to the identification of potential ochratoxin antagonists. Altex 14(4): 155-164
Obermayer-Straub, P.; Strassburg, C.P.; Manns, M.P. 2000: Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases. Canadian Journal of Gastroenterology 14(5): 429-439
George, J.; Gilburd, B.; Hojnik, M.; Levy, Y.; Langevitz, P.; Matsuura, E.; Koike, T.; Shoenfeld, Y. 1998: Target recognition of beta2-glycoprotein i (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPi in antibody binding. Journal of Immunology 160(8): 3917-3923
Habecker, B.A.; Asmus, S.A.; Francis, N.; Landis, S.C. 1997: Target regulation of VIP expression in sympathetic neurons. Annals of the new York Academy of Sciences 814: 198-208
Condat 1990: Target relaxation by walkers departing from a finite domain. Physical Review. A Atomic Molecular and Optical Physics 41(6): 3365-3368
Cho; Porile; Morrissey 1989: Target residues from the interaction of copper with 15-45 MeV/nucleon 12C ions. Physical Review. C Nuclear Physics 39(6): 2227-2236
Cho; Chung; Porile; Morrissey 1987: Target residues from the interaction of copper with 35 MeV/nucleon 12C ions. Physical Review. C Nuclear Physics 36(6): 2349-2358
Whitfield; Porile 1994: Target residues from the interaction of copper with 90 MeV/nucleon 6Li ions. Physical Review. C Nuclear Physics 49(1): 304-313
Montenegro; Meyerhof 1991: Target screening effect on the projectile electron-loss probability. Physical Review. A Atomic Molecular and Optical Physics 44(11): 7229-7233
Goudail, F.ço.; Réfrégier, P. 2002: Target segmentation in active polarimetric images by use of statistical active contours. Applied Optics 41(5): 874-883
Speulman, E.; van Asperen, R.; van der Laak, J.; Stiekema, W.J.; Pereira, A. 2000: Target selected insertional mutagenesis on chromosome IV of Arabidopsis using the En-i transposon system. Journal of Biotechnology 78(3): 301-312
Gamboz, N.; Russo, R.; Fox, E. 2000: Target selection difficulty, negative priming, and aging. Psychology and Aging 15(3): 542-550
Krauzlis, R.J.; Zivotofsky, A.Z.; Miles, F.A. 1999: Target selection for pursuit and saccadic eye movements in humans. Journal of Cognitive Neuroscience 11(6): 641-649
Huang, S.L.; Ding, B.; Li, J.; Yi, F.X.; Liu, W.L.; Yu, Q.S.; Guo, Z.G. 1999: Target selectivity of MAPK phosphorothioate antisense ODN on p42/p44, p38 MAPK, and JNK protein expression and its inhibitory effect on VSMC DNA synthesis. Zhongguo Yao Li Xue Bao 20(7): 613-617
Silver, M.D. 1994: Target self-attenuation extension to the Desobry and Boyer thick-target bremsstrahlung spectrum. Medical Physics 21(4): 577-579
Humphreys, M.S.; Tehan, G.; O'Shea, A.; Bolland, S.W. 2000: Target similarity effects: support for the parallel distributed processing assumptions. Memory and Cognition 28(5): 798-811
Eldridge, J. 1994: Target specific bargaining. Nursing Management 25(9): 82-83
Bohn, O.S.; Polka, L. 2001: Target spectral, dynamic spectral, and duration cues in infant perception of German vowels. Journal of the Acoustical Society of America 110(1): 504-515
Fleury, M.; Basset, F.; Bard, C.; Teasdale, N. 1998: Target speed alone influences the latency and temporal accuracy of interceptive action. Canadian Journal of Experimental Psychology 52(2): 84-92
Li, W.J.; Qian, H.N.; Lu, W.Y. 1994: Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposome and adriamycin. Zhonghua Fu Chan Ke Za Zhi 29(5): 296-298; 319
Tani, K. 2001: Target therapy for CML--applying maxizyme. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(12): 2439-2444
Coulombe, J.N.; Kos, K. 1997: Target tissue influence on somatostatin expression in the avian ciliary ganglion. Annals of the new York Academy of Sciences 814: 209-225
Withnell, J. 1993: Target to skin distance determination of oblique beams through a solid simulation table. Medical Dosimetry: Official Journal of the American Association of Medical Dosimetrists 18(2): 63-64
Capewell, A. 2002: Target treatment of female urinary dysfunction. Lancet 359(9308): 801
Pillutla, R.C.; Fisher, P.B.; Blume, A.J.; Goldstein, N.I. 2002: Target validation and drug discovery using genomic and protein-protein interaction technologies. Expert Opinion on Therapeutic Targets 6(4): 517-531
Taylor, M.F. 2001: Target validation and functional analyses using antisense oligonucleotides. Expert Opinion on Therapeutic Targets 5(3): 297-301
Dubrowski, A.; Lam, J.; Carnahan, H. 2000: Target velocity effects on manual interception kinematics. Acta Psychologica 104(1): 103-118
Kilo, J.; Baumer, H.; Czerny, M.; Hiesmayr, M.J.; Ploner, M.; Wolner, E.; Grimm, M. 2001: Target vessel revascularization without cardiopulmonary bypass in elderly high-risk patients. Annals of Thoracic Surgery 71(2): 537-542
Greiner, R.H. 1998: Target volume and indications of radiotherapy in breast carcinoma. Praxis 87(17): 595-601
Armstrong, J.G. 1998: Target volume definition for three-dimensional conformal radiation therapy of lung cancer. British Journal of Radiology 71(846): 587-594
Van Kampen, M.; Levegrün, S.; Wannenmacher, M. 1997: Target volume definition in radiation therapy. British Journal of Radiology 70(Special Issue): S25-S31
Caudry, M.; Ratoanina, J.L.; Escarmant, P.; Maire, J.P. 2001: Target volume in radiotherapy of gastric adenocarcinoma. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 5(5): 523-533
Hendrey; Nam; Guzdar; Ott 2000: Target waves in the complex ginzburg-landau equation. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(6 Part A): 7627-7631
Selby, T. 1996: Target your billing practices before Medicare does. Subacute Care 3(3): 17
McCarthy, R. 1999: Target your health dollars to the root causes. Business and Health 17(12): 23-24; 26-27
Moss, G. 2001: Target your market. Optometry 72(5): 335-336
Svensson, R.; Asell, M.; Näfstadius, P.; Brahme, A. 1998: Target, purging magnet and electron collector design for scanned high-energy photon beams. Physics in Medicine and Biology 43(5): 1091-1112
Yu; Liu; Lei; Yang; Pan; Wang; Sun 1989: Target-atom excitations in the collisions of He2+ ions with Na atoms. Physical Review. A General Physics 39(6): 2931-2932
Ohdaira; Matsushita; Takashima; Imanishi; Fukuzawa 1993: Target-atomic-number-dependent oscillations of equilibrium charge-state distributions of 50-500-keV/u hydrogen and boron emerging from solids. Physical Review. A Atomic Molecular and Optical Physics 47(1): 236-240
Gallagher, G.; Rae, C.P.; Watson, S.; Kinsella, J. 2001: Target-controlled alfentanil analgesia for dressing change following extensive reconstructive surgery for trauma. Journal of Pain and Symptom Management 21(1): 1-2
Hans, P. 1997: Target-controlled anesthesia in neurosurgery. what we are looking at. Acta Anaesthesiologica Belgica 48(4): 213-215
Bovill, J.G.; van den Nieuwenhuyzen, M.C. 1996: Target-controlled infusion delivery systems: application outside the operating room. Journal of Clinical Anesthesia 8(3 Suppl): 21s-25s
De Castro, V.; Godet, G.; Mencia, G.; Raux, M.; Coriat, P. 2003: Target-controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement. Anesthesia and Analgesia 96(1): 33-38 Table of Contents
Roblin, G.; Williams, A.R.; Whittet, H. 2001: Target-controlled infusion in sleep endoscopy. Laryngoscope 111(1): 175-176
Hans, P.; Bonhomme, V.; Born, J.D.; Maertens de Noordhoudt, A.; Brichant, J.F.; Dewandre, P.Y. 2000: Target-controlled infusion of propofol and remifentanil combined with bispectral index monitoring for awake craniotomy. Anaesthesia 55(3): 255-259
Kiyama, S.; Yoshikawa, T. 1998: Target-controlled infusion of propofol for the difficult airway. Anaesthesia and Intensive Care 26(5): 591-592
Lehmann, A.; Boldt, J.; Römpert, R.; Thaler, E.; Kumle, B.; Weisse, U. 2001: Target-controlled infusion or manually controlled infusion of propofol in high-risk patients with severely reduced left ventricular function. Journal of Cardiothoracic and Vascular Anesthesia 15(4): 445-450
Hirota, K.; Zsigmond, E.K. 1993: Target-controlled infusion systems. Anaesthesia 48(2): 176
Jenkins, S.; Lawton, G. 1999: Target-controlled infusions. Anaesthesia 54(6): 610
Milne, S.E.; Horgan, P.G.; Kenny, G.N.C. 2002: Target-controlled infusions of propofol and remifentanil with closed-loop anaesthesia for hepatic resection. Anaesthesia 57(1): 93
Kenny, G.N.; Sutcliffe, N.P. 1996: Target-controlled infusions: stress free anesthesia?. Journal of Clinical Anesthesia 8(3 Suppl): 15s-20s
Otteni, J.C. 1997: Target-controlled inhalation anesthesia or computer-controlled quantitative inhalation anesthesia. Annales Francaises d'Anesthesie et de Reanimation 16(5): 477-478
Leonard, I.E.; Myles, P.S. 2000: Target-controlled intravenous anaesthesia with bispectral index monitoring for thoracotomy in a patient with severely impaired left ventricular function. Anaesthesia and Intensive Care 28(3): 318-321
Billard, V.; Cazalaà, J.B.; Servin, F.; Viviand, X. 1997: Target-controlled intravenous anesthesia. Annales Francaises d'Anesthesie et de Reanimation 16(3): 250-273
Smith, I.; Thwaites, A.J. 1999: Target-controlled propofol vs. sevoflurane: a double-blind, randomised comparison in day-case anaesthesia. Anaesthesia 54(8): 745-752
Murdoch, J.A.; Hyde, R.A.; Kenny, G.N. 1999: Target-controlled remifentanil in combination with propofol for spontaneously breathing day-case patients. Anaesthesia 54(11): 1028-1031
Drube; Noffke; Schneider; Rogozik; Dose 1992: Target-current spectroscopy of reconstructing 5d-transition-metal surfaces as a tool for testing bulk-band-structure calculations. Physical Review. B Condensed Matter 45(8): 4390-4397
Lan, C.T.; Liu, J.C.; Ling, E.A.; Cheng, M.H.; Youn, S.C. 2000: Target-dependent axonal sprouting following vagal-hypoglossal nerve anastomosis in cats. Restorative Neurology and Neuroscience 17(2-3): 113-124
Jones, G.B.; Hynd, G.; Wright, J.M.; Purohit, A.; Plourde, G.W.; Huber, R.S.; Mathews, J.E.; Li, A.; Kilgore, M.W.; Bubley, G.J.; Yancisin, M.; Brown, M.A. 2001: Target-directed enediynes: designed estramycins. Journal of Organic Chemistry 66(11): 3688-3695
So, R.H.; Chung, G.K.; Goonetilleke, R.S. 1999: Target-directed head movements in a head-coupled virtual environment: predicting the effects of lags using Fitts' law. Human Factors 41(3): 474-486
Thumm; Bastug; Fricke 1995: Target-electronic-structure dependence in highly-charged-ion-C60 collisions. Physical Review. a Atomic Molecular and Optical Physics 52(4): 2955-2964
Krahl, D.; Petzoldt, D. 1994: Target-like hemosiderotic hemangioma. Further differential diagnosis of Kaposi sarcoma. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 45(1): 34-37
Punch, J.L.; Shovels, A.H.; Dickinson, W.W.; Calder, J.H.; Snead, C. 1995: Target-matched insertion gain derived from three different hearing aid selection procedures. Journal of the American Academy of Audiology 6(6): 425-432
Hernández-delRey, R.; Armario, P.; Martin-Baranera, M.; Sánchez, P.; Cárdenas, G.; Pardell, H. 1998: Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect. Blood Pressure Monitoring 3(6): 331-337
Christman, S.S. 1994: Target-related neologism formation in jargonaphasia. Brain and Language 46(1): 109-128
Biankin, S.A.; Jenkins, A.B.; Campbell, L.V.; Choi, K.L.; Forrest, Q.G.; Chisholm, D.J. 2003: Target-seeking behavior of plasma glucose with exercise in type 1 diabetes. Diabetes Care 26(2): 297-301
Luiten, R.M.; Fleuren, G.J.; Warnaar, S.O.; Litvinov, S.V. 1996: Target-specific activation of mast cells by immunoglobulin e reactive with a renal cell carcinoma-associated antigen. Laboratory Investigation; a Journal of Technical Methods and Pathology 74(2): 467-475
Fernandes, D.S.; Aye, R.W.; Garnett, D.J.; Denny, J. 2000: Target-specific rib biopsy using the gamma probe. American Journal of Surgery 179(5): 389-390
Yamazaki; Hülskötter; Breinig; DeSerio; Burgdörfer; Underwood; Gibbons; Sellin; Pepmiller 1986: Target-thickness dependence of the convoy-electron yield measured in coincidence with exit charge states in fast-ion-solid collisions. Physical Review. A General Physics 34(5): 4493-4496
Rothard; Caraby; Cassimi; Gervais; Grandin; Jardin; Jung; Billebaud; Chevallier; Groeneveld; Maier 1995: Target-thickness-dependent electron emission from carbon foils bombarded with swift highly charged heavy ions. Physical Review. A Atomic Molecular and Optical Physics 51(4): 3066-3078
Previc, F.H.; Naegele, P.D. 2001: Target-tilt and vertical-hemifield asymmetries in free-scan search for 3-D targets. Perception and Psychophysics 63(3): 445-457
Auble; Ball; Bertrand; Ferguson; Lee; Robinson; Young 1988: Target/projectile mass dependence of light ion yields from heavy ion collisions. Physical Review. C Nuclear Physics 37(1): 390-392
Anonymous 1988: Target: adolescents. Help in trying times. Profiles in healthcare marketing 1988(32): 33-47
Brems, S. 1987: Target: malnutrition. Results from Tamil Nadu. Mothers and Children 6(3): 1-5
Spath, P.L. 2002: Target: patient safety. Journal of Ahima 73(3): 26-33; Quiz: 35-36
Early, P. 1989: Target: seniors. Older Americans flock to services they want and ask for. Profiles in Healthcare Marketing 1989(33): 34-39
Marinik, L.M.; Arevalo, F. 1995: Target: technology, training, teamwork. Executive Housekeeping Today 16(4): 4-5
Staten, C. 1991: Target: terrorism. Emergency Medical Services 20(3): 30
Hallenbeck, P.L.; Stevenson, S.C. 2000: Targetable gene delivery vectors. Advances in Experimental Medicine and Biology 465: 37-46
Min, Z.; Gill, R.D.; Cortez, C.; Harvey, R.G.; Loechler, E.L.; DiGiovanni, J. 1996: Targeted a --> T and G --> T mutations induced by site-specific deoxyadenosine and deoxyguanosine adducts, respectively, from the (+)-anti-diol epoxide of dibenz[a,j]anthracene in M13mp7L2. Biochemistry 35(13): 4128-4138
Jordan 1999: Targeted Antiestrogens to Prevent Breast Cancer. Trends in Endocrinology and Metabolism: Tem 10(8): 312-317
Przyklenk; Hutsell; Hata; Whittaker 1998: Targeted Coronary Thrombolysis via "Pericardial" Administration of Lytic Agents?. Journal of Thrombosis and Thrombolysis 6(2): 83-88
Des Jarlais, D.C.; Padian, N.S.; Winkelstein, W. 1994: Targeted HIV-prevention programs. New England Journal of Medicine 331(21): 1451-1453
Marshall, R. 1980: Targeted Jobs Tax Credit program. Personnel Administrator 25(1): 46-47
Hutchinson, D. 2002: Targeted RM in industrial facilities. Occupational Health and Safety 71(7): 100-101
Koljesar, G.; Yoo, D. 2001: Targeted RNA recombination of the membrane and nucleocapsid protein genes between mouse hepatitis virus and bovine coronavirus. Journal of Veterinary Science 2(3): 149-157
Watson, W.S. 1998: Targeted Salmonella--a new way to image tumours?. Nuclear Medicine Communications 19(10): 1019
Panda, D.K.; Miao, D.; Tremblay, M.L.; Sirois, J.; Farookhi, R.; Hendy, G.N.; Goltzman, D. 2001: Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proceedings of the National Academy of Sciences of the United States of America 98(13): 7498-7503
Blanchard, E.M.; Iizuka, K.; Christe, M.; Conner, D.A.; Geisterfer-Lowrance, A.; Schoen, F.J.; Maughan, D.W.; Seidman, C.E.; Seidman, J.G. 1997: Targeted ablation of the murine alpha-tropomyosin gene. Circulation Research 81(6): 1005-1010
Kondoh, H. 1995: Targeted ablation of transcription factor genes. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 40(14): 2126-2133
Wang, Z.E.; Reiner, S.L.; Hatam, F.; Heinzel, F.P.; Bouvier, J.; Turck, C.W.; Locksley, R.M. 1993: Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. Journal of Immunology 151(4): 2077-2086
McDonald, G.A. 2002: Targeted adenoviral gene transfer to the kidney. Kidney International 61(1 Suppl): S42-S46
Bilbao, G.; Gómez-Navarro, J.; Curiel, D.T. 1998: Targeted adenoviral vectors for cancer gene therapy. Advances in Experimental Medicine and Biology 451: 365-374
Clemenson, N.D. 2000: Targeted advertising in medical journals. Archives of Family Medicine 9(9): 791
Allen, B.J. 1999: Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer. Australasian Radiology 43(4): 480-486
Babincová, M. 1999: Targeted and controlled release of drugs using magnetoliposomes. Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 48(1): 27-29
Anderson, D.R.; Grillo-López, A.; Varns, C.; Chambers, K.S.; Hanna, N. 1997: Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochemical Society Transactions 25(2): 705-708
Gutheil, J.C.; Campbell, T.N.; Pierce, P.R.; Watkins, J.D.; Huse, W.D.; Bodkin, D.J.; Cheresh, D.A. 2000: Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(8): 3056-3061
Tonetti, D.A.; Jordan, V.C. 1997: Targeted antiestrogens. Progress in Clinical and Biological Research 396: 245-255
Bentrem, D.J.; Jordan, V.C. 1999: Targeted antiestrogens for the prevention of breast cancer. Oncology Research 11(9): 401-407
Shankar, R.A.; Hideg, K.; Zweier, J.L.; Kuppusamy, P. 2000: Targeted antioxidant properties of N-[(tetramethyl-3-pyrroline-3-carboxamido)propyl]phthalimide and its nitroxide metabolite in preventing postischemic myocardial injury. Journal of Pharmacology and Experimental Therapeutics 292(3): 838-845
Richardson, T.H.; Griffin, K.J.; Jung, F.; Raucy, J.L.; Johnson, E.F. 1997: Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C51. Archives of Biochemistry and Biophysics 338(2): 157-164
Demetri, G.D. 2001: Targeted approaches for the treatment of thrombocytopenia. Oncologist 6(Suppl 5): 15-23
Marangolo, M. 2002: Targeted biological treatments in NSCLC. Farnesyl transferase inhibitors. I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 1(4): S49
Reske, S.N.; Bunjes, D.; Buchmann, I.; Seitz, U.; Glatting, G.; Neumaier, B.; Kotzerke, J.; Buck, A.; Martin, H.; Döhner, H.; Bergmann, L. 2001: Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation. European Journal of Nuclear Medicine 28(7): 807-815
Nagamitsu, A.; Konno, T.; Oda, T.; Tabaru, K.; Ishimaru, Y.; Kitamura, N. 1998: Targeted cancer chemotherapy for VX2 tumour implanted in the colon with lipiodol as a carrier. European Journal of Cancer 34(11): 1764-1769
Miller, M. 2000: Targeted cancer therapies attempt to hit the bull's-eye. Journal of the National Cancer Institute 92(23): 1878-1879
McCann, M.C.; Stacey, N.J.; Roberts, K. 2000: Targeted cell death in xylogenesis. Symposia of the Society for Experimental Biology 52: 193-201
Konno, T.; Oda, T.; Nagamitsu, A.; Tabaru, K.; Yamashita, R.; Kai, Y. 1996: Targeted chemotherapy of hepatocellular carcinoma using Lipiodol as a carrier. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(11): 1392-1399
Konno, T.; Tabaru, K.; Isogai, M.; Nagamitsu, A.; Oda, T. 1998: Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(Suppl 1): 10-18
Dash, B.C.; Harikrishnan, T.A.; Goila, R.; Shahi, S.; Unwalla, H.; Husain, S.; Banerjea, A.C. 1998: Targeted cleavage of HIV-1 envelope gene by a DNA enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion. Febs Letters 431(3): 395-399
Casavant, N.C.; Hardies, S.C. 1993: Targeted cloning of a subfamily of LINE-1 elements by subfamily-specific LINE-1-PCR. Mammalian Genome: Official Journal of the International Mammalian Genome Society 4(4): 193-201
Gupta, H.; Weissleder, R. 1996: Targeted contrast agents in MR imaging. Magnetic Resonance Imaging Clinics of North America 4(1): 171-184
Wick, M.R.; Swanson, P.E. 2002: Targeted controls in clinical immunohistochemistry: a useful approach to quality assurance. American Journal of Clinical Pathology 117(1): 7-8
Colosimo, A.; Goncz, K.K.; Novelli, G.; Dallapiccola, B.; Gruenert, D.C. 2001: Targeted correction of a defective selectable marker gene in human epithelial cells by small DNA fragments. Molecular Therapy: the Journal of the American Society of Gene Therapy 3(2): 178-185
Chan, P.P.; Lin, M.; Faruqi, A.F.; Powell, J.; Seidman, M.M.; Glazer, P.M. 1999: Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide. Journal of Biological Chemistry 274(17): 11541-11548
Li, Z.H.; Liu, D.P.; Yin, W.X.; Guo, Z.C.; Liang, C.C. 2001: Targeted correction of the point mutations of beta-thalassemia and targeted mutagenesis of the nucleotide associated with HPFH by RNA/DNA oligonucleotides: potential for beta-thalassemia gene therapy. Blood Cells Molecules and Diseases 27(2): 530-538
Szepeshazi, K.; Schally, A.V.; Nagy, A.; Halmos, G.; Groot, K. 1997: Targeted cytotoxic luteinizing hormone releasing hormone (LH-RH) anlalogs inhibit growth of estrogen independent MXT mouse mammary cancers in vivo by decreasing cell proliferation and inducing apoptosis. Anti-Cancer Drugs 8(10): 974-987
Wang, Z.B.; Wu, F.; Wang, Z.L.; Zhang, Z.; Zou, J.Z.; Liu, C.; Liu, Y.G.; Cheng, G.; Du, Y.H.; He, Z.C.; Gu, M.L.; Wang, Z.G.; Feng, R. 1997: Targeted damage effects of high intensity focused ultrasound (HIFU) on liver tissues of Guizhou Province miniswine. Ultrasonics Sonochemistry 4(2): 181-182
Poncelet, M.; Cassier-Chauvat, C.; Leschelle, X.; Bottin, H.; Chauvat, F. 1998: Targeted deletion and mutational analysis of the essential (2Fe-2S) plant-like ferredoxin in Synechocystis PCC6803 by plasmid shuffling. Molecular Microbiology 28(4): 813-821
Tessarollo, L.; Tsoulfas, P.; Donovan, M.J.; Palko, M.E.; Blair-Flynn, J.; Hempstead, B.L.; Parada, L.F. 1997: Targeted deletion of all isoforms of the trkC gene suggests the use of alternate receptors by its ligand neurotrophin-3 in neuronal development and implicates trkC in normal cardiogenesis. Proceedings of the National Academy of Sciences of the United States of America 94(26): 14776-14781
Sugita, M.; Svab, Z.; Maliga, P.; Sugiura, M. 1997: Targeted deletion of sprA from the tobacco plastid genome indicates that the encoded small RNA is not essential for pre-16S rRNA maturation in plastids. Molecular and General Genetics: Mgg 257(1): 23-27
Faust, P.L.; Hatten, M.E. 1997: Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. Journal of Cell Biology 139(5): 1293-1305
Glick, A.B.; Lee, M.M.; Darwiche, N.; Kulkarni, A.B.; Karlsson, S.; Yuspa, S.H. 1994: Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes and Development 8(20): 2429-2440
Ohlemiller, K.K.; McFadden, S.L.; Ding, D.L.; Flood, D.G.; Reaume, A.G.; Hoffman, E.K.; Scott, R.W.; Wright, J.S.; Putcha, G.V.; Salvi, R.J. 1999: Targeted deletion of the cytosolic Cu/Zn-superoxide dismutase gene (Sod1) increases susceptibility to noise-induced hearing loss. Audiology and Neuro-Otology 4(5): 237-246
Wurfel, M.M.; Monks, B.G.; Ingalls, R.R.; Dedrick, R.L.; Delude, R.; Zhou, D.; Lamping, N.; Schumann, R.R.; Thieringer, R.; Fenton, M.J.; Wright, S.D.; Golenbock, D. 1997: Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. Journal of Experimental Medicine 186(12): 2051-2056
Dunø, M.; Bendixen, C.; Krejci, L.; Thomsen, B. 1999: Targeted deletions created in yeast vectors by recombinational excision. Nucleic Acids Research 27(8): E1
Guo, P.; Ma, J.; Li, S.; Guo, Z.; Adams, A.L.; Gallo, J.M. 2001: Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model. Cancer ChemoTherapy and Pharmacology 48(2): 169-176
Bartholomew, R.M.; Carmichael, E.P.; Findeis, M.A.; Wu, C.H.; Wu, G.Y. 1995: Targeted delivery of antisense DNA in woodchuck hepatitis virus-infected woodchucks. Journal of Viral Hepatitis 2(6): 273-278
Biessen, E.A.; Vietsch, H.; Rump, E.T.; Fluiter, K.; Bijsterbosch, M.K.; van Berkel, T.J. 2000: Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo. Methods in Enzymology 314: 324-342
Chari 1998: Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy. Advanced Drug Delivery Reviews 31(1-2): 89-104
Orson, F.M.; Kinsey, B.M.; Bhogal, B.S.; Song, L.; Densmore, C.L.; Barry, M.A. 2003: Targeted delivery of expression plasmids to the lung via macroaggregated polyethylenimine-albumin conjugates. Methods in Molecular Medicine 75: 575-590
Klibanov 1999: Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Advanced Drug Delivery Reviews 37(1-3): 139-157
Ganderton, D. 1999: Targeted delivery of inhaled drugs: current challenges and future goals. Journal of Aerosol Medicine: the Official Journal of the International Society for Aerosols in Medicine 12(Suppl 1): S3-S8
Liang, K.W.; Hoffman, E.P.; Huang, L. 2000: Targeted delivery of plasmid DNA to myogenic cells via transferrin-conjugated peptide nucleic acid. Molecular Therapy: the Journal of the American Society of Gene Therapy 1(3): 236-243
Kawakami, S.; Munakata, C.; Fumoto, S.; Yamashita, F.; Hashida, M. 2000: Targeted delivery of prostaglandin E1 to hepatocytes using galactosylated liposomes. Journal of Drug Targeting 8(3): 137-142
Saji, H. 1999: Targeted delivery of radiolabeled imaging and therapeutic agents: bifunctional radiopharmaceuticals. Critical Reviews in Therapeutic Drug Carrier Systems 16(2): 209-244
Neri, D. 2001: Targeted delivery of tissue factor to tumor neovasculature for cancer therapy. Haemostasis 31(Suppl 1): 21-22
Park, J.-H.; Lee, M.-K.; Kim, H.-S.; Kim, K.L.; Cho, E.-W. 2003: Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope. Journal of Viral Hepatitis 10(1): 70-79
Hayden, M.J.; Sharp, P.J. 2001: Targeted development of informative microsatellite (SSR) markers. Nucleic Acids Research 29(8): E44
Yu, L.; Gu, F.; Zhang, C.; Xie, S.; Guo, Y. 1998: Targeted diagnosis and treatment of superficial bladder cancer with monoclonal antibody BDI-1. Chinese Medical Journal 111(5): 404-407
Matsuyama, T.; Kimura, T.; Kitagawa, M.; Pfeffer, K.; Kawakami, T.; Watanabe, N.; Kündig, T.M.; Amakawa, R.; Kishihara, K.; Wakeham, A. 1993: Targeted disruption of IRF-1 or IRF-2 results in abnormal type i IFN gene induction and aberrant lymphocyte development. Cell 75(1): 83-97
Jablonski, M.M.; Iannaccone, A. 2000: Targeted disruption of Müller cell metabolism induces photoreceptor dysmorphogenesis. Glia 32(2): 192-204
Forrest, D.; Yuzaki, M.; Soares, H.D.; Ng, L.; Luk, D.C.; Sheng, M.; Stewart, C.L.; Morgan, J.I.; Connor, J.A.; Curran, T. 1994: Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13(2): 325-338
Xu, Y.; Cheng, G.; Baltimore, D. 1996: Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5(5): 407-415
Carruthers, V.B.; Navarro, M.; Cross, G.A. 1996: Targeted disruption of expression site-associated gene-1 in bloodstream-form Trypanosoma brucei. Molecular and Biochemical Parasitology 81(1): 65-79
Kalitsis, P.; Fowler, K.J.; Earle, E.; Hill, J.; Choo, K.H. 1998: Targeted disruption of mouse centromere protein C gene leads to mitotic disarray and early embryo death. Proceedings of the National Academy of Sciences of the United States of America 95(3): 1136-1141
Ohno, H.; Goto, S.; Taki, S.; Shirasawa, T.; Nakano, H.; Miyatake, S.; Aoe, T.; Ishida, Y.; Maeda, H.; Shirai, T. 1994: Targeted disruption of the CD3 eta locus causes high lethality in mice: modulation of Oct-1 transcription on the opposite strand. EMBO Journal 13(5): 1157-1165
Mitchison, H.M.; Bernard, D.J.; Greene, N.D.; Cooper, J.D.; Junaid, M.A.; Pullarkat, R.K.; de Vos, N.; Breuning, M.H.; Owens, J.W.; Mobley, W.C.; Gardiner, R.M.; Lake, B.D.; Taschner, P.E.; Nussbaum, R.L. 1999: Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. the Batten Mouse Model Consortium [corrected. Neurobiology of Disease 6(5): 321-334
Tretter, V.; Hauer, B.; Nusser, Z.; Mihalek, R.M.; Höger, H.; Homanics, G.E.; Somogyi, P.; Sieghart, W. 2001: Targeted disruption of the GABA(A) receptor delta subunit gene leads to an up-regulation of gamma 2 subunit-containing receptors in cerebellar granule cells. Journal of Biological Chemistry 276(13): 10532-10538
Köster, A.; Saftig, P.; Matzner, U.; von Figura, K.; Peters, C.; Pohlmann, R. 1993: Targeted disruption of the M(r) 46,000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins. EMBO Journal 12(13): 5219-5223
Toda, K.; Takeda, K.; Okada, T.; Akira, S.; Saibara, T.; Kaname, T.; Yamamura, K.; Onishi, S.; Shizuta, Y. 2001: Targeted disruption of the aromatase P450 gene (Cyp19) in mice and their ovarian and uterine responses to 17beta-oestradiol. Journal of Endocrinology 170(1): 99-111
Evers, M.; Saftig, P.; Schmidt, P.; Hafner, A.; McLoghlin, D.B.; Schmahl, W.; Hess, B.; von Figura, K.; Peters, C. 1996: Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis Vi. Proceedings of the National Academy of Sciences of the United States of America 93(16): 8214-8219
Bohne, W.; Hunter, C.A.; White, M.W.; Ferguson, D.J.; Gross, U.; Roos, D.S. 1998: Targeted disruption of the bradyzoite-specific gene BAG1 does not prevent tissue cyst formation in Toxoplasma gondii. Molecular and Biochemical Parasitology 92(2): 291-301
Barnes, D.E.; Stamp, G.; Rosewell, I.; Denzel, A.; Lindahl, T. 1998: Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Current Biology: Cb 8(25): 1395-1398
Inoue, H.; Noumi, T.; Nagata, M.; Murakami, H.; Kanazawa, H. 1999: Targeted disruption of the gene encoding the proteolipid subunit of mouse vacuolar H(+)-ATPase leads to early embryonic lethality. Biochimica et Biophysica Acta 1413(3): 130-138
Klinger, J.R.; Warburton, R.R.; Pietras, L.; Oliver, P.; Fox, J.; Smithies, O.; Hill, N.S. 2002: Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy. American Journal of Physiology. Heart and Circulatory Physiology 282(1): H58-H65
Liu, C.; Litscher, E.S.; Mortillo, S.; Sakai, Y.; Kinloch, R.A.; Stewart, C.L.; Wassarman, P.M. 1996: Targeted disruption of the mZP3 gene results in production of eggs lacking a zona pellucida and infertility in female mice. Proceedings of the National Academy of Sciences of the United States of America 93(11): 5431-5436
Miyata, M.; Kudo, G.; Lee, Y.H.; Yang, T.J.; Gelboin, H.V.; Fernandez-Salguero, P.; Kimura, S.; Gonzalez, F.J. 1999: Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. Journal of Biological Chemistry 274(34): 23963-23968
Durbin, J.E.; Hackenmiller, R.; Simon, M.C.; Levy, D.E. 1996: Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84(3): 443-450
Takeda, K.; Noguchi, K.; Shi, W.; Tanaka, T.; Matsumoto, M.; Yoshida, N.; Kishimoto, T.; Akira, S. 1997: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proceedings of the National Academy of Sciences of the United States of America 94(8): 3801-3804
Brady, J.P.; Garland, D.; Duglas-Tabor, Y.; Robison, W.G.; Groome, A.; Wawrousek, E.F. 1997: Targeted disruption of the mouse alpha A-crystallin gene induces cataract and cytoplasmic inclusion bodies containing the small heat shock protein alpha B-crystallin. Proceedings of the National Academy of Sciences of the United States of America 94(3): 884-889
Wang, S.; Gebre-Medhin, S.; Betsholtz, C.; Stålberg, P.; Zhou, Y.; Larsson, C.; Weber, G.; Feinstein, R.; Oberg, K.; Gobl, A.; Skogseid, B. 1998: Targeted disruption of the mouse phospholipase C beta3 gene results in early embryonic lethality. Febs Letters 441(2): 261-265
Morales, C.R.; Zhao, Q.; El-Alfy, M.; Suzuki, K. 2000: Targeted disruption of the mouse prosaposin gene affects the development of the prostate gland and other male reproductive organs. Journal of Andrology 21(6): 765-775
Johnson, M.T.; Yang, H.S.; Magnuson, T.; Patel, M.S. 1997: Targeted disruption of the murine dihydrolipoamide dehydrogenase gene (Dld) results in perigastrulation lethality. Proceedings of the National Academy of Sciences of the United States of America 94(26): 14512-14517
Wynick, D.; Small, C.J.; Bloom, S.R.; Pachnis, V. 1998: Targeted disruption of the murine galanin gene. Annals of the new York Academy of Sciences 863: 22-47
Hoffman, L.M.; Nix, D.A.; Benson, B.; Boot-Hanford, R.; Gustafsson, E.; Jamora, C.; Menzies, A.S.; Goh, K.L.; Jensen, C.C.; Gertler, F.B.; Fuchs, E.; Fässler, R.; Beckerle, M.C. 2003: Targeted disruption of the murine zyxin gene. Molecular and Cellular Biology 23(1): 70-79
Papadopoulos, V.; Amri, H.; Li, H.; Boujrad, N.; Vidic, B.; Garnier, M. 1997: Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. Journal of Biological Chemistry 272(51): 32129-32135
Lee, S.S.; Gonzalez, F.J. 1996: Targeted disruption of the peroxisome proliferator-activated receptor alpha gene, PPAR alpha. Annals of the New York Academy of Sciences 804: 524-529
Klein, R.; Smeyne, R.J.; Wurst, W.; Long, L.K.; Auerbach, B.A.; Joyner, A.L.; Barbacid, M. 1993: Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75(1): 113-122
Ponniah, S.; Wang, D.Z.; Lim, K.L.; Pallen, C.J. 1999: Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Current Biology: Cb 9(10): 535-538
Koyasu, S.; Hussey, R.E.; Clayton, L.K.; Lerner, A.; Pedersen, R.; Delany-Heiken, P.; Chau, F.; Reinherz, E.L. 1994: Targeted disruption within the CD3 zeta/eta/phi/Oct-1 locus in mouse. EMBO Journal 13(4): 784-797
Garnett, M.C. 2001: Targeted drug conjugates: principles and progress. Advanced Drug Delivery Reviews 53(2): 171-216
Liu, J.; Kolar, C.; Lawson, T.A.; Gmeiner, W.H. 2001: Targeted drug delivery to chemoresistant cells: folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells. Journal of Organic Chemistry 66(17): 5655-5663
Terasaki, T.; Pardridge, W.M. 2000: Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport). Journal of Drug Targeting 8(6): 353-355
Somogyi, G.; Buchwald, P.; Bodor, N. 2002: Targeted drug delivery to the central nervous system via phosphonate derivatives (anionic delivery system for testosterone). Die Pharmazie 57(2): 135-137
Mathias, N.R.; Kim, K.J.; Lee, V.H. 1996: Targeted drug delivery to the respiratory tract: solute permeability of air-interface cultured rabbit tracheal epithelial cell monolayers. Journal of Drug Targeting 4(2): 79-86
Qian, Z.M.; Li, H.; Sun, H.; Ho, K. 2002: Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacological Reviews 54(4): 561-587
Pyhälä, R.; Ziegler, T.; Lumio, J. 2000: Targeted drugs against influenza--how will this affect the epidemics?. Duodecim; Laaketieteellinen Aikakauskirja 116(1): 13-15
Osborn, D.A.; Jeffery, H.E.; Bredemeyer, S.L.; Polverino, J.M.; Reid, S. 2000: Targeted early rescue surfactant in ventilated preterm infants using the click test. Pediatrics 106(3): E30
Fishman, A.; Lorberboum-Galski, H. 1997: Targeted elimination of cells expressing the high-affinity receptor for IgE (Fc epsilon RI) by a Pseudomonas exotoxin-based chimeric protein. European Journal of Immunology 27(2): 486-494
Otto, T. 1999: Targeted enamel erosion/abrasion. the treatment of enamel dysplasia by a microabrasion technic. Schweizer Monatsschrift für Zahnmedizin 109(5): 488-497
Kopidakis, G.; Aubry, S.; Tsironis, G.P. 2001: Targeted energy transfer through discrete breathers in nonlinear systems. Physical Review Letters 87(16): 165501
Aartsma-Rus, A.; Bremmer-Bout, M.; Janson, A.A.M.; den Dunnen, J.T.; van Ommen, G-Jan.B.; van Deutekom, J.C.T. 2002: Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. Neuromuscular Disorders: Nmd 12 Suppl. 1: S71-S77
Tascou, S.; Nayernia, K.; Meinhardt, A.; Schweyer, S.; Engel, W.; Trappe, R.; Burfeind, P. 2001: Targeted expression of SV40 large tumour antigen (TAg) induces a transient enhancement of spermatocyte proliferation and apoptosis. Molecular Human Reproduction 7(12): 1123-1131
Grewal, I.; Gu, L.; Tseng, S.; Rollins, B.J. 2000: Targeted expression of chemokines in vivo. Methods in Molecular Biology 138: 243-251
Schipani, E.; Lanske, B.; Hunzelman, J.; Luz, A.; Kovacs, C.S.; Lee, K.; Pirro, A.; Kronenberg, H.M.; Jüppner, H. 1997: Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proceedings of the National Academy of Sciences of the United States of America 94(25): 13689-13694
Keller, A.; Sweeney, S.T.; Zars, T.; O'Kane, C.J.; Heisenberg, M. 2002: Targeted expression of tetanus neurotoxin interferes with behavioral responses to sensory input in Drosophila. Journal of Neurobiology 50(3): 221-233
Khachatryan, A.; Guerder, S.; Palluault, F.; Cote, G.; Solimena, M.; Valentijn, K.; Millet, I.; Flavell, R.A.; Vignery, A. 1997: Targeted expression of the neuropeptide calcitonin gene-related peptide to beta cells prevents diabetes in NOD mice. Journal of Immunology 158(3): 1409-1416
Jarzynski, C. 2002: Targeted free energy perturbation. Physical Review. E Statistical Nonlinear and Soft Matter Physics 65(4 Pt 2a): 046122
Xiang, Y.; Cole-Strauss, A.; Yoon, K.; Gryn, J.; Kmiec, E.B. 1997: Targeted gene conversion in a mammalian CD34+-enriched cell population using a chimeric RNA/DNA oligonucleotide. Journal of Molecular Medicine 75(11-12): 829-835
Yoon, K.; Cole-Strauss, A.; Kmiec, E.B. 1996: Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA.DNA oligonucleotide. Proceedings of the National Academy of Sciences of the United States of America 93(5): 2071-2076
Kenner, O.; Kneisel, A.; Klingler, Jürgen.; Bartelt, B.; Speit, Günter.; Vogel, W.; Kaufmann, D. 2002: Targeted gene correction of hprt mutations by 45 base single-stranded oligonucleotides. Biochemical and Biophysical Research Communications 299(5): 787-792
Richardson, P.D.; Kren, B.T.; Steer, C.J. 2001: Targeted gene correction strategies. Current Opinion in Molecular Therapeutics 3(4): 327-337
Zakhary, R.; Poss, K.D.; Jaffrey, S.R.; Ferris, C.D.; Tonegawa, S.; Snyder, S.H. 1997: Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide. Proceedings of the National Academy of Sciences of the United States of America 94(26): 14848-14853
Sarkar, D.P.; Ramani, K.; Tyagi, S.K. 2002: Targeted gene delivery by virosomes. Methods in Molecular Biology 199: 163-173
Mata, M.; Glorioso, J.C.; Fink, D.J. 2002: Targeted gene delivery to the nervous system using herpes simplex virus vectors. Physiology and Behavior 77(4-5): 483-488
Sato, T.; Fukui, T.; Atomi, H.; Imanaka, T. 2003: Targeted gene disruption by homologous recombination in the hyperthermophilic archaeon Thermococcus kodakaraensis KOD1. Journal of Bacteriology 185(1): 210-220
Seeley, R.J.; Woods, S.C.; D'Alessio, D. 2000: Targeted gene disruption in endocrine research--the case of glucagon-like peptide-1 and neuroendocrine function. Endocrinology 141(2): 473-475
Bonilla, F.A.; Kokron, C.M.; Swinton, P.; Geha, R.S. 1997: Targeted gene disruption of murine CD7. International Immunology 9(12): 1875-1883
Kojima, T. 2002: Targeted gene disruption of natural anticoagulant proteins in mice. International Journal of Hematology 76(Suppl 2): 36-39
Kagan, R.M.; Niewmierzycka, A.; Clarke, S. 1997: Targeted gene disruption of the Caenorhabditis elegans L-isoaspartyl protein repair methyltransferase impairs survival of dauer stage nematodes. Archives of Biochemistry and Biophysics 348(2): 320-328
Parekh-Olmedo, H.; Czymmek, K.; Kmiec, E.B. 2001: Targeted gene repair in mammalian cells using chimeric RNA/DNA oligonucleotides and modified single-stranded vectors. Science's Stke: Signal Transduction Knowledge Environment 73: Pl1
Kmiec, E.B.; Ye, S.; Peng, L. 2000: Targeted gene repair in mammalian cells using chimeric oligonucleotides. Genetic Engineering 22: 23-31
Tomita, N.; Morishita, R.; Yamamoto, K.; Higaki, J.; Dzau, V.J.; Ogihara, T.; Kaneda, Y. 2002: Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes. Journal of Gene Medicine 4(5): 527-535
Askari, A.T.; Penn, M.S. 2002: Targeted gene therapy for the treatment of cardiac dysfunction. Seminars in Thoracic and Cardiovascular Surgery 14(2): 167-177
Wu, C.H.; Walton, C.M.; Wu, G.Y. 2002: Targeted gene transfer to liver using protein-DNA complexes. Methods in Molecular Medicine 69: 15-23
Skyler, J.S. 1998: Targeted glycemic control in type 2 diabetes. Journal of the Florida Medical Association 85(2): 7-15
Anilkumar, G.; Nair, L.G.; Fraser-Reid, B. 2000: Targeted glycosyl donor delivery for site-selective glycosylation. Organic Letters 2(17): 2587-2589
Burkhalter, D.K.; Farmer-Dougan, V.A.; Nordstrom, C.R. 1997: Targeted goal setting: helping nurses manage a turbulent work environment. Journal of Nursing Management 5(2): 89-96
Yip, W.; Berman, P. 2001: Targeted health insurance in a low income country and its impact on access and equity in access: Egypt's school health insurance. Health Economics 10(3): 207-220
Williams, J.R.; Nokes, D.J.; Anderson, R.M. 1996: Targeted hepatitis B vaccination--a cost effective immunisation strategy for the UK?. Journal of Epidemiology and Community Health 50(6): 667-673
Jordan, V.C. 1993: Targeted hormone therapy for breast cancer. Hospital Practice 28(3): 55-62
Babich; Fischman 1999: Targeted imaging of infection. Advanced Drug Delivery Reviews 37(1-3): 237-252
Dayton, P.A.; Ferrara, K.W. 2002: Targeted imaging using ultrasound. Journal of Magnetic Resonance Imaging: Jmri 16(4): 362-377
Garrity, R.R. 1999: Targeted immune design using RNA immunization. Annals of the new York Academy of Sciences 894: 124-129
Bonn, D. 1998: Targeted immunosuppressant on trial for rheumatoid arthritis. Molecular Medicine Today 4(7): 277
Turuo, T. 1999: Targeted immunotherapy for malignant tumors. Japanese Journal of Clinical Hematology 40(6): 476-479
Pierson, R.N.; Conary, J.T.; Langford, G.; White, D.G.; Brigham, K.L.; Parker, R.E. 1996: Targeted in vivo gene transfection modulated hyperacute rejection of pig lungs perfused with human blood. Transplantation Proceedings 28(2): 763
Just, U.; Katsuno, M.; Stocking, C.; Spooncer, E.; Dexter, M. 1993: Targeted in vivo infection with a retroviral vector carrying the interleukin-3 (multi-CSF) gene leads to immortalization and leukemic transformation of primitive hematopoietic progenitor cells. Growth Factors 9(1): 41-55
Ruf, S.; Kössel, H.; Bock, R. 1997: Targeted inactivation of a tobacco intron-containing open reading frame reveals a novel chloroplast-encoded photosystem I-related gene. Journal of Cell Biology 139(1): 95-102
Sowell, M.O.; Ye, C.; Ricupero, D.A.; Hansen, S.; Quinn, S.J.; Vassilev, P.M.; Mortensen, R.M. 1997: Targeted inactivation of alphai2 or alphai3 disrupts activation of the cardiac muscarinic K+ channel, IK+Ach, in intact cells. Proceedings of the National Academy of Sciences of the United States of America 94(15): 7921-7926
Andrä, K.; Lassmann, H.; Bittner, R.; Shorny, S.; Fässler, R.; Propst, F.; Wiche, G. 1997: Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes and Development 11(23): 3143-3156
Rudolph, U.; Bradley, A.; Birnbaumer, L. 1994: Targeted inactivation of the Gi2 alpha gene with replacement and insertion vectors: analysis in a 96-well plate format. Methods in Enzymology 237: 366-386
Forss-Petter, S.; Werner, H.; Berger, J.; Lassmann, H.; Molzer, B.; Schwab, M.H.; Bernheimer, H.; Zimmermann, F.; Nave, K.A. 1997: Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. Journal of Neuroscience Research 50(5): 829-843
Lauer, P.; Metzner, H.J.; Zettlmeissl, G.; Li, M.; Smith, A.G.; Lathe, R.; Dickneite, G. 2002: Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thrombosis and Haemostasis 88(6): 967-974
Yang, W.C.; Mathew, J.; Velcich, A.; Edelmann, W.; Kucherlapati, R.; Lipkin, M.; Yang, K.; Augenlicht, L.H. 2001: Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Research 61(2): 565-569
Kapila, S.; Xie, Y. 1998: Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthrodial joint fibrocartilaginous cells but not in synoviocytes. Laboratory Investigation; a Journal of Technical Methods and Pathology 78(8): 925-938
Bellicha, T.C.; Campbell, K.A. 1975: Targeted information concept: the National Clearinghouse for Alcohol Information. Drug Information Journal 9(2-3): 199-205
Schmidt, M.; Wels, W. 1996: Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha. British Journal of Cancer 74(6): 853-862
Weitzman, M.D.; Young, S.M.; Cathomen, T.; Samulski, R.J. 2003: Targeted integration by adeno-associated virus. Methods in Molecular Medicine 76: 201-219
Gregory, C.; Cifaldi, M.; Tanner, L.A. 1999: Targeted intervention programs: creating a customized practice model to improve the treatment of allergic rhinitis in a managed care population. American Journal of Managed Care 5(4): 485-496
Field, M.L.; Price, J.; Niang, C.; N'tcha, J.; Zwane, I.T.; Lurie, M.; Nxumalo, M.; Dialmy, A.; Manhart, L.; Gebre, A.; Saidel, T.; Dallabetta, G. 1998: Targeted intervention research studies on sexually transmitted diseases (STD): methodology, selected findings and implications for STD service delivery and communications. Aids 12 Suppl. 2: S119-S126
Howard, A.C.; O'Brien, D.A.; Cleveland, W.H.; Gordon, S. 1999: Targeted intervention to improve compliance in an urban hemodialysis population. Nephrology News and Issues 13(2): 27; 31-34
Agostinelli, B.; Demers, K.; Garrigan, D.; Waszynski, C. 1994: Targeted interventions. use of the mini-mental state exam. Journal of Gerontological Nursing 20(8): 15-23
Vaidya, J.S.; Baum, M.; Tobias, J.S.; D'Souza, D.P.; Naidu, S.V.; Morgan, S.; Metaxas, M.; Harte, K.J.; Sliski, A.P.; Thomson, E. 2001: Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(8): 1075-1080
Tuszynski, M.H.; Smith, D.E.; Roberts, J.; McKay, H.; Mufson, E. 1998: Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate beta-amyloid plaque deposition. Experimental Neurology 154(2): 573-582
Tamura, M.; Shimizu, K.; Yamada, M.; Miyao, Y.; Hayakawa, T.; Ikenaka, K. 1997: Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells. Human Gene Therapy 8(4): 381-391
Pasqual, E..M..; Cagol, P..P.. 2001: Targeted laparoscopic abdominal adhesiolysis. Surgical Endoscopy 15(1): 100
Waxman, A.B.; Einarsson, O.; Seres, T.; Knickelbein, R.G.; Warshaw, J.B.; Johnston, R.; Homer, R.J.; Elias, J.A. 1998: Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. Journal of Clinical Investigation 101(9): 1970-1982
Tuschl, T.; Zamore, P.D.; Lehmann, R.; Bartel, D.P.; Sharp, P.A. 1999: Targeted mRNA degradation by double-stranded RNA in vitro. Genes and Development 13(24): 3191-3197
Mason, B.W.; Donnelly, P.D. 2000: Targeted mailing of information to improve uptake of measles, mumps, and rubella vaccine: a randomised controlled trial. Communicable Disease and Public Health 3(1): 67-68
Liebelt, E.L. 1998: Targeted management strategies for cardiovascular toxicity from tricyclic antidepressant overdose: the pivotal role for alkalinization and sodium loading. Pediatric Emergency Care 14(4): 293-298
Stephens, B. 1990: Targeted marketing builds physician referrals. Profiles in Healthcare Marketing 39: 68-71
Lundy, D. 1991: Targeted marketing. the teleservices hub. Southern Hospitals 57(4): 24-25
Jack, T.; Sieburth, L.; Meyerowitz, E. 1997: Targeted misexpression of AGAMOUS in whorl 2 of Arabidopsis flowers. Plant Journal: for Cell and Molecular Biology 11(4): 825-839
Schlitter, J.; Engels, M.; Krüger, P. 1994: Targeted molecular dynamics: a new approach for searching pathways of conformational transitions. Journal of Molecular Graphics 12(2): 84-89
Dematteo, R.P.; Maki, R.G.; Antonescu, C.; Brennan, M.F. 2003: Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumor. Current Problems in Surgery 40(3): 144-193
Myers, J.N.; Holsinger, F.Christopher.; Bekele, B.Nebiyou.; Li, E.; Jasser, S.A.; Killion, J.J.; Fidler, I.J. 2002: Targeted molecular therapy for oral cancer with epidermal growth factor receptor blockade: a preliminary report. Archives of Otolaryngology--Head and Neck Surgery 128(8): 875-879
Valley, V.T.; Stahmer, S.A. 2001: Targeted musculoarticular sonography in the detection of joint effusions. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 8(4): 361-367
Singer, M.J.; Podyminogin, M.A.; Metcalf, M.A.; Reed, M.W.; Brown, D.A.; Gamper, H.B.; Meyer, R.B.; Wydro, R.M. 1999: Targeted mutagenesis of DNA with alkylating RecA assisted oligonucleotides. Nucleic Acids Research 27(24): E38
Hayward, M.D.; Low, M.J. 1999: Targeted mutagenesis of the murine opioid system. Results and Problems in Cell Differentiation 26: 169-191
McNamara, P.J.; Bradley, G.A.; Songer, J.G. 1994: Targeted mutagenesis of the phospholipase D gene results in decreased virulence of Corynebacterium pseudotuberculosis. Molecular Microbiology 12(6): 921-930
Rabinowitz, J.E.; Rutishauser, U.; Magnuson, T. 1996: Targeted mutation of Ncam to produce a secreted molecule results in a dominant embryonic lethality. Proceedings of the National Academy of Sciences of the United States of America 93(13): 6421-6424
Alcamo, E.; Mizgerd, J.P.; Horwitz, B.H.; Bronson, R.; Beg, A.A.; Scott, M.; Doerschuk, C.M.; Hynes, R.O.; Baltimore, D. 2001: Targeted mutation of TNF receptor i rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. Journal of Immunology 167(3): 1592-1600
Ohlemiller, K.K.; McFadden, S.L.; Ding, D.L.; Lear, P.M.; Ho, Y.S. 2000: Targeted mutation of the gene for cellular glutathione peroxidase (Gpx1) increases noise-induced hearing loss in mice. Journal of the Association for Research in Otolaryngology: Jaro 1(3): 243-254
Heys, S.D.; Wahle, K.W. 2001: Targeted nutrition in the critically ill: a therapeutic modality for the new millennium?. Nutrition 17(1): 57-58
Rodríguez-Gallardo, L.; Climent, V.; Garciá-Martínez, V.; Schoenwolf, G.C.; Alvarez, I.S. 1997: Targeted over-expression of FGF in chick embryos induces formation of ectopic neural cells. International Journal of Developmental Biology 41(5): 715-723
Hsu, S.Y.; Lai, R.J.; Finegold, M.; Hsueh, A.J. 1996: Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis, and increased germ cell tumorigenesis. Endocrinology 137(11): 4837-4843
Dominey, A.M.; Wang, X.J.; King, L.E.; Nanney, L.B.; Gagne, T.A.; Sellheyer, K.; Bundman, D.S.; Longley, M.A.; Rothnagel, J.A.; Greenhalgh, D.A. 1993: Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth and Differentiation: the Molecular Biology Journal of the American Association for Cancer Research 4(12): 1071-1082
Inabnet, W.B.; Biertho, L. 2002: Targeted parathyroid surgery: a series of 100 consecutive patients. Annales de Chirurgie 127(10): 751-756
Inabnet, W.B.; Dakin, G.F.; Haber, R.S.; Rubino, F.; Diamond, E.J.; Gagner, M. 2002: Targeted parathyroidectomy in the era of intraoperative parathormone monitoring. World Journal of Surgery 26(8): 921-925
Dahms, G.H.; Seidel, H.; Jung, A.H. 2002: Targeted penetration and release of ascorbic acid by the use of multiple phase technology. Journal of Cosmetic Science 53(5): 293-296
O'Connor, T.A.; Bondurant, H.H.; Siddiqui, J. 1997: Targeted perinatal drug screening in a rural population. Journal of Maternal-Fetal Medicine 6(2): 108-110
Defleur, P.; De Beule, F. 1995: Targeted periodontal maintenance. Revue Belge de Medecine Dentaire 50(4): 53-62
Preskorn, S. 1994: Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline. International Clinical Psychopharmacology 9(Suppl 3): 13-19
Del Governatore, M.; Hamblin, M.R.; Piccinini, E.E.; Ugolini, G.; Hasan, T. 2000: Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates. British Journal of Cancer 82(1): 56-64
Vetter, C. 2000: Targeted practice service for the patient. Help with smoking cessation. MMW Fortschritte der Medizin 142(26-27): 35-36
Han, H.K.; Amidon, G.L. 2000: Targeted prodrug design to optimize drug delivery. Aaps Pharmsci 2(1): E6
Singhal, S.; Ellis, R.W.; Jones, S.G.; Miller, S.J.; Fisher, N.C.; Hastings, J.G.; Mutimer, D.J. 2000: Targeted prophylaxis with amphotericin B lipid complex in liver transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 6(5): 588-595
Traviglia, S.L.; Datwyler, S.A.; Yan, D.; Ishihama, A.; Meares, C.F. 1999: Targeted protein footprinting: where different transcription factors bind to RNA polymerase. Biochemistry 38(48): 15774-15778
Higai, K.; Shibukawa, K.; Muto, S.; Matsumoto, K. 2003: Targeted proteo-glycomics analysis of Sialyl Lewis X antigen expressing glycoproteins secreted by human hepatoma cell line. Analytical Sciences: the International Journal of the Japan Society for Analytical Chemistry 19(1): 85-92
Crouch, D.H.; Fincham, V.J.; Frame, M.C. 1996: Targeted proteolysis of the focal adhesion kinase pp125 FAK during c-MYC-induced apoptosis is suppressed by integrin signalling. Oncogene 12(12): 2689-2696
Meller, S. 1997: Targeted radiotherapy for neuroblastoma. Archives of Disease in Childhood 77(5): 389-391
Roa, W.H.; Miller, G.G.; McEwan, A.J.; McQuarrie, S.A.; Tse, J.; Wu, J.; Wiebe, L.I. 1998: Targeted radiotherapy of multicell neuroblastoma spheroids with high specific activity [125I]meta-iodobenzylguanidine. International Journal of Radiation Oncology Biology Physics 41(2): 425-432
Bruland, O.S.; Skretting, A.; Solheim, O.P.; Aas, M. 1996: Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. a new promising approach. Acta Oncologica 35(3): 381-384
Burn, C.; Ramsey, N.; Garforth, S.J.; Almo, S.; Jacobs, W.R.; Herold, B.C. 2018: A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice from Lethal Skin Challenge with Clinical Isolates of HSV-1 and HSV-2. Journal of Infectious Diseases 217(5): 754-758
Rogers, B.E.; Zinn, K.R.; Lin, C.-Y.; Chaudhuri, T.R.; Buchsbaum, D.J. 2002: Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector. Cancer 94(4 Suppl): 1298-1305
Brini, M.; Pinton, P.; Pozzan, T.; Rizzuto, R. 1999: Targeted recombinant aequorins: tools for monitoring [Ca2+] in the various compartments of a living cell. Microscopy Research and Technique 46(6): 380-389
Adair, G.M.; Scheerer, J.B.; Brotherman, A.; McConville, S.; Wilson, J.H.; Nairn, R.S. 1998: Targeted recombination at the Chinese hamster APRT locus using insertion versus replacement vectors. Somatic Cell and Molecular Genetics 24(2): 91-105
Lavi, E.; Kuo, L.; Haluskey, J.A.; Masters, P.S. 1998: Targeted recombination between MHV-2 and MHV-A59 to study neurotropic determinants of MHV. Advances in Experimental Medicine and Biology 440: 543-547
Risseeuw, E.; Offringa, R.; Franke-van Dijk, M.E.; Hooykaas, P.J. 1995: Targeted recombination in plants using Agrobacterium coincides with additional rearrangements at the target locus. Plant Journal: for Cell and Molecular Biology 7(1): 109-119
Young, W.S.; Shepard, E.; DeVries, A.C.; Zimmer, A.; LaMarca, M.E.; Ginns, E.I.; Amico, J.; Nelson, R.J.; Hennighausen, L.; Wagner, K.U. 1998: Targeted reduction of oxytocin expression provides insights into its physiological roles. Advances in Experimental Medicine and Biology 449: 231-240
Ardittis, S. 1991: Targeted reintegration of expatriate brains into developing countries of origin: the EEC-IOM experience in Central America. International Migration 29(3): 371-388
Iler, N.; Goodwin, A.J.; McInerney, J.; Nemeth, M.J.; Pomerantz, O.; Layon, M.E.; Lowrey, C.H. 1999: Targeted remodeling of human beta-globin promoter chromatin structure produces increased expression and decreased silencing. Blood Cells Molecules and Diseases 25(1): 47-60
Kaspar, B.K.; Erickson, D.; Schaffer, D.; Hinh, L.; Gage, F.H.; Peterson, D.A. 2002: Targeted retrograde gene delivery for neuronal protection. Molecular Therapy: the Journal of the American Society of Gene Therapy 5(1): 50-56
Liu, J.; Li, Y.-H.; Xue, C.-F.; Ding, J.; Gong, W.-D.; Zhao, Y.; Huang, Y.-X. 2003: Targeted ribonuclease can inhibit replication of hepatitis B virus. World Journal of Gastroenterology 9(2): 295-299
Merinova, L.K.; Timofeeva, E.V.; Simova, I.K. 1997: Insertion mutations in Pseudomonas pseudomallei genome induced by transposons Tn10. Tn9, and Tn5. Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 46(1): 14-17
Kennedy, M.M. 1997: Targeted searches: a double-edged sword. Physician Executive 23(7): 52-54
Sreedhara, A.; Cowan, J.A. 2001: Targeted site-specific cleavage of HIV-1 viral Rev responsive element by copper aminoglycosides. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 6(2): 166-172
Indra, A.K.; Li, M.; Brocard, J.; Warot, X.; Bornert, J.M.; Gérard, C.; Messaddeq, N.; Chambon, P.; Metzger, D. 2000: Targeted somatic mutagenesis in mouse epidermis. Hormone Research 54(5-6): 296-300
Venes, J.; Dauser, R. 1998: Targeted studies as a learning tool in outcomes assessment. Surgical Neurology 49(6): 655-659
Glaser, T.; Gerenkamp, M.; Fröhlich, R. 2002: Targeted synthesis of ferromagnetically coupled complexes with modified 1,3,5-trihydroxybenzene ligands. Angewandte Chemie 41(20): 3823-3825
Schaffer, D.V.; Lauffenburger, D.A. 2000: Targeted synthetic gene delivery vectors. Current Opinion in Molecular Therapeutics 2(2): 155-161
Kubo, T.; Sugita, T.; Shimose, S.; Nitta, Y.; Ikuta, Y.; Murakami, T. 2001: Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters. International Journal of Oncology 18(1): 121-125
Whelan, J. 2002: Targeted taxane therapy for cancer. Drug Discovery Today 7(2): 90-92
Geyer, S.J.; Johnson, P.C. 2002: Targeted therapeutics and implications for pathologists. American Journal of Clinical Pathology 118(1): 144; Author Reply 144